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ABSTRACT

PROPERTIES OF CONDUCTANCE AND INHIBITION OF
PROTON CHANNELS: M2 FROM INFLUENZA A VIRUS
AND FO FROM ESCHERICHIA COLI ATP SYNTHASE.

J. Craig Moffat
Department of Physiology and Developmental Biology
Master of Science

Proton channels are essential for many of the processes of life. The influenza
A viral protein M2 is responsible for sensing the conditions necessary for viral RNA
release. The proton-translocating FOF1 ATPase (ATP synthase) uses a proton gradient
to drive adenosine triphosphate (ATP) synthesis. We have directly measured proton
uptake in vesicles containing reconstituted M2 or FO by monitoring external pH after
addition of valinomycin to vesicles with 100-fold diluted external [K+]. This proton
flux assay was utilized to quantify proton flux through single M2 and FO channels.
Contrary to previous reports, proton uptake by M2 was not significantly altered
by acidification of the extravesicular pH. We conclude that pH only weakly affects

proton flux through M2 in the pH range of 5.4 - 7.0. Theoretical analysis utilized for
such vesicle uptake assays illuminates the appropriate time scale of the initial slope
and an important limitation that must be placed on inferences about channel ion
selectivity. The rise in pH over 10 seconds after ionophore addition yielded timeaveraged single channel conductances of 0.35±0.2 aS and 0.72±0.4 aS at pH 5.4 and
7.0 respectively. Such a low time-average conductance implies that M2 is only
conductive 10-6-10-4 of the time. M2 selectivity for hydrogen over potassium is ~107.
FO translocates protons across membranes, converting electrochemical energy
to rotational inertia. Previous experiments have been partially confounded by a
contaminating channel, CL, which co-purifies with FO and leaks cations. CL activity is
shown to not decrease following deletion of the previously uncharacterized yraM open
reading frame of E. coli. FO purified from a deletion strain lacking yraM is just as
active as FO purified from the wild-type strain. Using FO from the deletion strain, the
single-hit hypothesis of DCCD inhibition of passive proton flux through FO was
examined. A DCCD-induced reduction in ATP synthase activity correlates with a
reduction in the total initial slope, the number of functional FO per µg protein, and the
single channel proton flux. At least 2 DCCD per FO are required to totally inactivate
passive proton flux. M2 and FO have similar single channel conductances but
different open probabilities.
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Chapter 1 – Introduction and Review of Pertinent Literature
Proton channels and pumps are ubiquitous in nature and play a crucial role in
maintaining homeostasis. A review of all mechanisms of proton translocation through
lipid membranes is not feasible in this work. The interested reader should see
DeCoursey’s excellent and extensive review of that topic (1). Uses of proton channels
and pumps range from bacterial channels that guard against acidic conditions;
mammalian pumps that acidify the stomach via a H+-K+ antiporter; eukaryotic and
prokaryotic ATP synthase that uses a hydrogen electrochemical gradient to convert
ADP and phosphate to ATP; and an influenza viral proton channel that triggers viral
uncoating after cellular infection. This report will focus on the M2 proton channel
from Influenza A virus and the F1FO ATPase (ATP synthase) from E. coli.
M2 Proton Channel from Influenza A Virus
The Influenza A life cycle is summarized in Figure 1-1. Hay (2) and Grambas
(3) have described the viral life cycle. The virus adheres to the host cell using
hemagglutinin (HA), found in the viral membrane, to bind sialic acid, one of the
carbohydrates found on the host cell membrane (4). The virus is then encapsulated
into an endosome. The low pH triggers M2 activity, acidifying the interior of the
virus, which facilitates viral fusion to the endosome and release of ssRNA into the
cellular matrix. After RNA replication and transcription, the virus forms by budding
from the cellular membrane, perhaps from lipid rafts where the neuraminidase and
hemagglutinin have been shown to localize (5,6). Neuraminidase cleaves sialic acid
from the polysaccharide structure of the host cell’s membrane, releasing the newly
1

formed virus (4,7,8). Amantadine has been shown to block M2 activity, inhibiting
viral synthesis by preventing viral acidification and therefore RNA release. Another
class of anti-viral drugs that target the flu virus is called neuraminidase inhibitors,
which act to prevent viral budding and to cause clumping of free viral particles. In
some situations, M2 is thought to prevent acidification of the golgi apparatus to
protect acid-sensitive hemagglutinins.
M2 is useful to study for two reasons. First, the simplicity of the channel
relative to other more complex proton channels, such as FO, make M2 a useful model
to study. The active form of M2 consists of a homotetramer (9,10). Figure 1-2 is a
molecular model of the M2 tetramer showing the protein backbone and histidine-37,
which are implicated as the proton selectivity filter. There is evidence that M2 is more
permeable to protons at lower pH (3), a process termed acid-gating.
Second, the mechanism of action of amantadine is of interest because although
it has been available by prescription since 1987 to treat flu (type A), the mechanism of
inhibition has not been fully clarified. In Figure 1-2 amantadine has been overlaid in a
space-filling representation near the selectivity pore (as simulated by Mario Pinoli).
Although its exact M2 binding location is unknown, it may be an intrachannel (11,12)
or an allosteric blocker (13). This figure shows that if amantadine is able to reach
histidine-37, it is not likely to pass through due to steric hindrance. Greater
understanding of amantadine activity may lead to more effective M2 blockers and
perhaps better anti-viral drugs.

2

F1FO ATPase from E. coli
Proton transport is also a key step in the production of ATP by the F1FO
ATPase. ATP synthase is vital for life in organisms from both the plant and animal
kingdoms. It catalyzes the last step in oxidative metabolic pathways using an
electrochemical gradient to make ATP from ADP and phosphate. It is noteworthy that
this mechanism can run in the reverse direction so that ATP hydrolysis can be used to
pump protons up an electrochemical gradient to acidify compartments within cells or
organs.
Figure 1-3 shows the structure of ATP synthase. FO is the proton transport
sector that is embedded in the membrane. Researchers have demonstrated that FO
rotates in the plane of the membrane (14). It is composed of a ring of c subunits, two
b subunits, and one a subunit. The exact number of c subunits has been debated in the
literature for decades (summarized in Table 1-1). Knowing this number is critical to
determine how many protons are required for each ATP generation.
The F1 sector of the F1FO ATPase is the site of ATP formation or hydrolysis.
It is composed of three sets of

and

subunit pairs and one each of , , and

subunits. The ATP is formed within the

pairs by the rotation of the subunit such

that 3 ATPs are produced (or hydrolyzed) each full rotation. The subunit is linked to
the c subunit ring, which rotates in the membrane based on the electrochemical proton
gradient that is created by metabolic pathways.
Mechanically, the FOF1 ATPase is interesting to study because it is a true
motor. Like an electrical generator, ATP synthase has a stator (a, b and subunits)
and a rotor (c ring, and ) (15). Rotation of c with respect to a and b is then
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transferred to the stalk ( and ) producing conformational changes in

and

to make

ATP. ATP synthase represents one of the smallest true biological motors.
Researchers have quantified the rate of proton flux through FO. Although estimates
vary by more than a factor of 1,000 (70 H+/FO/sec (16), 105 H+/FO/sec (17)), the two
most recent publications estimate the flux to be 6240 protons per second per FO (18)
and 3100 protons per second per FO (19).
N,N'Dicyclohexylcarbodiimide (DCCD) has been shown to inhibit FO function
by covalently binding to aspartate-61 on the c subunit of FO to form an N-acyl urea
(20). Thus DCCD selectively blocks FO, presumably inhibiting proton flux by making
the proton binding site unavailable. Since there are many c subunits per FO, the
number of DCCD required to block proton flux per FO has been investigated but
remains unclear. As further described in Chapter 3, there is evidence in support that
modification of just one c subunit by DCCD will block transport (single-hit model).
There is also evidence in support that more than one c subunit must be “hit” by DCCD
to block transport (multiple-hit model).
Specific Aims
There are two main aims of my master’s thesis:
1. Examine the proposed acid gating of M2
2. Examine the proposed single-hit stoichiometry of DCCD inhibition of FO.
A significant obstacle for Aim 1 was designing comparable buffers at different
pHs in which to run the experiments. The four histidines at position 37 of M2 have
been shown to have pKa values of 8.2, 8.2, ~5.7, and <4. It seemed most useful to
study pHs above 8.0, between 8.0 and 5.7, and below 5.7 (21). Simulations by Dr.
4

Busath and Steve Later suggested that the proton flux assay results were very sensitive
to the pH at which the experiment was run in relation to the pKa of the buffer in which
the experiment was run. For reliable results they suggested that the studies be
performed 0.2 pH units below the pKa of the weak acid used to buffer the extra- and
intra-vesicular pHs, confirming an earlier hypothesis.
Design of the three buffer systems for pHs 5.4, 7.0, and 9.4 was accomplished,
as reported in Chapter 2. However, 75% of all experiments at pH 9.4 failed to give
any signal, perhaps due to the buffer glycine permeating the vesicles. At the other two
pHs no evidence of acid gating was found. In a separate experiment, gramicidin was
incorporated into vesicles as a positive control for leakiness to K+. This experiment
proved useful in strongly demonstrating that perfect selectivity for protons against
potassium is not essential for the proton flux assay to work. As discussed in Chapter
2, a gramicidin dose response curve revealed that if too much of a mildly or weakly
selective channel is added to the vesicles the proton flux assay will fail. Chapter 2
also presents a detailed mathematical model of the proton flux assay, as modeled by
Dr. Busath. He contributed much of the discussion of that chapter which is being
submitted for publication.
In regards to Aim 2, examining the proposed single-hit stoichiometry of
DCCD inhibition of FO, there are three possible results. First, Hermolin and
Fillingame (22) concluded that one DCCD molecule inactivates ATPase activity,
which they called the single-hit model. The single-hit model of ATPase inactivation is
often assumed to apply to passive proton translocation as well. However, previous
research by Kopecky et al. (23) and Glaser et al. (24) showed that while one DCCD
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per FOF1 ATPase was sufficient to maximally inhibit ATPase function, two DCCD per
FO were required to maximally inhibit passive proton flux, with a reduced block
occurring at 1 DCCD per FO (single-hit concentration). More recently Dmirtiev et al.
(25) attempted to show that mutation of one Asp61 is sufficient to inhibit FO activity.
Incorporation of one c subunit with an Asp61Gly mutation appears to inhibit FO
activity. However, mutation of Asp61 to the structurally similar but non-protonatable
Asn failed to show such potency.
As discussed further in Chapter 3, our assay will be able to distinguish between
the single-hit and the multiple-hit hypotheses. Using FO that is purified after partial
inhibition of ATPase activity by DCCD, we will determine extent of inhibition of
passive proton flux. By comparing the proton flux inhibition to the inhibition of
ATPase activity we can distinguish between the models in the following manner. If
the single hit hypothesis is correct, the expected result from the proton flux assay
would be: the single channel flux (H+/FO/sec) remains unchanged, the number of
functional FO is reduced, and the initial slope (H+/sec) is reduced. If the second
hypothesis is correct, i.e. it requires 2 (or more) DCCD/FO to inhibit passive proton
flux but 1 DCCD/FO to inhibit ATPase activity, we will observe a reduction in the
single channel flux (H+/FO/sec), an unchanged number of functional FO‘s, but still a
reduction in the initial flux (H+/sec).
General Methods
Proton Flux Assay
In order to accomplish Aims 1 and 2, I will need to be able to measure the
number of protons that go through individual channels. The proton flux assay was
6

adapted to study FO by the Woodbury lab as described in Franklin et al (19), Dr.
Franklin’s dissertation, and Chapter 3. This assay has been adapted in Dr. Busath’s
lab to study M2, as detailed in Chapter 2. The basic idea of the proton flux assay is
summarized in Chapter 2 and as follows. Dr. Brusilow or Dr. Gao both ship purified
FO or M2, respectively, to our lab. The protein is then incorporated into vesicles with
high concentrations of intravesicular potassium and buffer. A pH probe records
changes in pH of the weakly buffered external solution during the following steps:
1. The extravesicular solution is continuously stirred and the pH monitored.
After the extravesicular pH stabilizes, vesicles are added.
2. Valinomycin, a potassium transporter, is added to the solution, allowing
potassium to diffuse out of the vesicles down its concentrations gradient. This
creates a net negative charge in the vesicles slowing the efflux and drawing
protons into the vesicles through functional proton channels. This is detected
by the pH probe as basification of the extravesicular solution.
3. CCCP, a proton transporter, is added allowing any vesicles without functional
proton channels to equilibrate their negative charge. This acts as a positive
control for the presence of vesicles and as a way to check the incorporation of
functional channels into our vesicles.
4. The buffer strength of the extravesicular solution is then determined by backtitrating the solution with one or more additions of HCl.
To observe drug sensitivity of the proton channels, the appropriate blocker is
preincubated with vesicles during or before step 1.

7

Analysis of the data is performed using several customized Excel spreadsheets
I created. The raw data is obtained from the probe, which is in volts. This is plotted
versus time. The slope of the valinomycin signal over 10 seconds is fitted to a straight
line. The average height of the back-titrations is then used to convert the slope (in
volts/sec) to moles H+/sec. This is then divided by the number of vesicles, which is
estimated to be 4 x 1011 based on an assumed diameter of 250 nm, 9 mg/ml lipid, and
63 Å2 for the area of one lipid head group. For actual analysis of experiments
performed in these studies the true size of each batch of vesicles was determined using
Dynamic Light Scattering (DLS) after vesicle sonication or extrusion through a sizing
filter. The methods for the individual studies are more carefully detailed in Chapters 2
and 3.
The FO studies were performed under Dr. Dixon Woodbury’s guidance. The
M2 studies were performed under Dr. David Busath’s guidance. Dr. William
Brusilow, Professor of Biochemistry at Wayne State University School of Medicine, is
an expert in ATP synthase and a longtime collaborator with Dr. Woodbury and
performed the yraM deletion, the ATPase inhibition and FO extraction techniques (as
described in Chapter 3). I did a two-week rotation in his laboratory during the
summer of 2005, learning biochemical techniques associated with FO purification. Dr.
Philip Gao is a longtime collaborator with Dr. Busath and provided the M2.
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Figures

Figure 1-1 – Influenza A virus life cycle taken from (26) with emphasis on the roles
of M2, hemagglutinin, and neuraminidase. M2 plays a key role in recognizing the
cellular pH environment and triggering fusion of the virus capsid to the endosomal
membrane when an acidification is detected.
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Figure 1-2 – Model of M2 structure by Mario Pinoli with histidine 37 shown in a ball
and stick model. Amantadine (space filling model) has been superimposed on the
image to emphasize the constriction created by the four histidines.
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Figure 1-3 – Structure of FOF1 ATPase as reported in Aksimentiev (27). The FO
sector is the membrane bound portion that translocates protons. F1 is the cytoplasmic
domain that functions either as an ATPase or ATP synthase. FO rotation drives ATP
synthesis. Conversely, ATP hydrolysis can drive proton flux through FO.
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# c subunits / FO

Reference

Year

8-14

(28,29)

1982, 1989

12

(30)

1998

10

(31)

1999

14

(32)

2000

11

(33,34)

2003, 2001

10

(35)

2004

Table 1-1 – Summary of the reported number of c subunits per FO sector. There is
still uncertainty in the number as various groups continue to report different answers
under different conditions. It has been suggested that the actual number of c subunits
in a newly produced FO may be varied by a cell in response to different enivormental
conditions.
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Abstract
Influenza A virus M2 protein is known to form acid-activated, protonselective, amantadine-sensitive channels. We have directly measured proton uptake in
vesicles containing reconstituted M2 by monitoring external pH after addition of
valinomycin to vesicles with 100-fold diluted external [K+]. Proton uptake was not
significantly altered by acidification. Under neutral conditions, external addition of 1
mM amantadine produced a reduction in proton flux consistent with randomly ordered
channels. Amantadine block was reduced at pH 5.4. In accordance with a previous
study of reconstituted M2 using a pH sensitive dye to monitor intravesicular pH (1),
we conclude that bath pH weakly or does not significantly affect proton flow in the pH
range of 5.4 - 7.0 for the reconstituted system, contrary to results from
electrophysiological studies. Theoretical analysis of the relaxation to Donnan
equilibrium utilized for such vesicle uptake assays illuminates the appropriate time
scale of the initial slope and an important limitation that must be placed on inferences
about channel ion selectivity. The rise in pH over 10 seconds after ionophore addition
yielded time-averaged single channel conductances of 0.35 ± 0.20 aS and 0.72 ± 0.42
aS at pH 5.4 and 7.0 respectively, an order of magnitude lower than was previously
reported in vesicles. Assuming complete membrane incorporation and tetramerization
of the reconstituted protein, such a low time-average conductance in the face of the
previously observed single channel conductance (6 pS at pH 3) implies a channel Po
of 10-6-10-4. M2 is ~107 selective for hydrogen over potassium.
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Introduction
The influenza virus M2 protein, target of the antiviral drugs, amantadine and
rimantadine, forms an acid-activated proton-conducting ion channel which functions
during uncoating and maturation by modifying the pH in virions as well as in transGolgi vesicles (2,3). The M2 channel is known to be highly selective for protons and
has low permeability for other physiological ions according to reversal potential
studies (4). The ion channel activity has been observed in whole cell Xenopus
oocytes, mammalian cells, and yeast cells (2,4,5,6,7,8) and in planar lipid bilayers (9).
This protein is a homotetramer of 97 amino acid (10,11) residues with 23 amino acids
of the N-terminus oriented extracellularly, a single internal hydrophobic domain of 19
residues that acts as a transmembrane domain and forms the pore of channel, and a 54
residue cytoplasmic tail. Histidine37 (His37) within the transmembrane domain has
been implicated in the activation and proton selectivity of the channel and may be
involved in proton translocation (8). Tryptophan41 (Trp41) has been shown to
influence the pH dependent characteristics of the channel (12).
The shape of the channel has been well characterized. M2 is a symmetric or
pseudosymmetric tetramer (13) with the membrane spanning region being a lefthanded coiled coil (14,15). The helices are separated by 8 Å and the Trp41 on the ith
helix and His37 of the ith + 1 helix are paired, being separated by only 3.9Å (16). The
helical tilt pivots near His37 and is flexible to allow the membrane spanning region to
fit within the bilayer thickness (17). This accounts for the variety of tilt angles from
the bilayer normal of 15° to 38° reported in a variety of lipid systems
(14,17,18,19,20). Using hydrogen/deuterium exchange with the whole protein Tian et
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al. (21) showed the presence of an aqueous pore. These data support the notion that
M2 homotetramers form an ion conduction pathway.
The mechanisms of selective M2 proton conductivity (22) and pH activation
(23) are matters of current debate. Two main selective conductivity mechanisms have
been suggested: gated Grotthus conductance (24) and shuttling (25). In the gated
Grotthus mechanism, conductivity is achieved when water molecules are able to
penetrate the channel throughout, forming a continuous, conductive proton wire. In
the shuttling mechanism, the histidines are directly involved in the proton transfer
mechanism. A biprotonated histidine intermediate is transiently formed, leading to
rapid proton release at the opposite side of the histidine ring. Regeneration occurs
through tautomerization or flipping of the imidazole ring. A detailed kinetic analysis
of the M2 current, which fits either mechanism, has been presented by Lear (26). An
intermediate mechanism involving water molecules on either side of the imidazole
rings serving as the shuttling agent has been suggested based on simulations (27).
Details of the protein structure and dynamics underlying selective proton transport are
still far from settled.
Conceptually, one would expect the term “acid-activation” to refer to increased
flux protons at lower pH, above and beyond what one would expects from mass-action
(28), modified by saturation (4); or, to increased probability of the open state (Po) for
single channels. Although proton current does go up by 2-10 fold as pH is reduced by
1.5-2 pH units (2,4,6,28,29,30,31) the increase is generally an order of magnitude
lower than expected from mass-action, let alone with acid-gating in addition to massaction. The increase is even lower in the one previously reported reconstitution
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experiment (1), where a pH change of 1.4 pH units induced only a 2-fold increase in
vesicle proton uptake. These sub-mass-action increases could be due to saturation of
an obligatory site in the proton transport pathway. Clear experimental evidence of
acid-activation can be observed when extracellular fluid is basified: whole cell
outward M2 current is decreased, even though the driving force on protons is
increased (4). For reconstituted M2, where single channel currents have been
observed, single channel currents increase with decreasing pH as expected from massaction (modulated by saturation, (9)), but Po changes have not been determined, so no
evidence of acid-gating is yet available at the single channel level.
Proton translocation into vesicles with reconstituted M2 proteins has been
measured previously using an intravesicular pH sensitive dye (1,32). Here, we report
the direct measurement of extra-vesicular pH changes associated with the permeability
of M2 in vesicles. We used the pH electrode method reported earlier (33,34) to
examine the effects of amantadine and variation in pH. The protein channel activity
was monitored by measuring the change in pH of the weakly buffered external
solutions. As with previous studies, determining the number of functional M2
proteins in our assay was difficult because of the possibility of variable incorporation,
variable oligomerization (or non-functional incorporation), and non-uniform
partitioning of the protein into the liposomal membranes. In this study, we have
determined the average proton flux per vesicle. Dividing by the nominal number of
M2 tetramers per vesicle we determine the time-averaged single channel conductance
of M2. Some of the results have been presented previously in preliminary form
(35,36,37).
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Materials and Methods
Purification and Reconstitution of M2 from E. coli.
M2 protein was expressed and purified using previously published methods
(38). Briefly, the M2 protein, Udorn variety with a six-His tag at the C-terminus and
serine substitutions for C19 and C50 was expressed in BL21 (DE3) cells using the
PET 39 plasmid and purified from exclusion bodies with a Ni affinity column or using
DEAE. Gel electrophoresis revealed the presence of single band in a sodium
dodecylsulphate gel (Figure 2-1). Sequence variants containing a His-tag at the Nterminal, His-tag cleaved with Tobacco Etch Virus (TEV) protease, or His37 mutated
to alanine (H37A) were also expressed and purified similarly and used for the study.
Protein concentration was determined using the bicinchoninic acid method. The
protein was reconstituted into 1,2-dimyristotl-sn-glycero-3-phosphocholine (DMPC)
and 1,2-dimyristotl-sn-glycero-3-[phosphoro-rac-(1-glyercerol)] (DMPG) lipids (4:1
molar ratio; Avanti Polar Lipids, Alabaster, AL) at a 1:5 protein:lipid (w:w) ratio
using 1% n-octyl -D-glucopyranoside (O.G.) and then dialyzed three times. The
dialyzed sample was centrifuged and resuspended as proteoliposomes in aqueous
solution.
Reconstitution of M2 protein in liposomes.
This step involved two procedures. First protein-free lipid vesicles were
prepared and then these vesicles were mixed with M2 proteoliposomes by freeze thaw
sonication. The size of the resulting liposomes was measured by dynamic light
scattering (DLS, 90Plus Particle Size Analyzer, Brookhaven Instruments Corporation,
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Holtsville, NY). For experiments at pH 7 and pH 5 different intravesicular and
extravesicular buffers were used.
Preparation of Lipid Vesicles.
Stock solutions of L-6-phosphatidlyethanolamine (PE), L- phosphatidylcholine (PC), L-6-phosphatidylserine (PS) from brain, and cholesterol
each at 10 mg/ml in chloroform were mixed to a molar ratio of 4:1:1:2 in a small test
tube (hereafter 4112) and the solvent evaporated under nitrogen. For pH 7.0 the dry
lipids were solubilized in a solution of 120 mM KH2PO4, 120 mM K2HPO4, 150 mM
NaCl and 20 mM KCl. The solution was titrated to pH 7 with KOH. The molarity of
total potassium is approximately 215 mM after mixing (1:1) with M2 vesicles
containing pure water. This corresponds to a potassium activity inside the fused
vesicles of 140 mM. It is lower than total potassium because of binding to phosphate.
For pH 5.4, the dry lipids were solubilized in a solution of 120 mM K3citrate, 120 mM
KH2citrate, and 120 mM NaCl titrated to pH 5.4 with KOH. The molarity of total
potassium is approximately 300 mM after dilution. This correlates with a potassium
activity of approximately 200 mM. Since the vesicles were always diluted 1:100 in
translocation buffer during the assay, the Nernst potential for potassium after addition
of valinomycin across the vesicular membrane will be the same at pH 7.0 and 5.4.
The suspension was mixed by vortexing vigorously for 10 minutes. It was
then sonicated in a bath sonicator (Sonicor SC-4U, Sonicor Instrument Corporation,
Copiague, NY) for 4 minutes and 30 seconds.
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Preparation of M2 Mixed Lipid Vesicles
Equal volumes of 4112 vesicles and the M2 proteoliposomes were mixed (M2
mixed vesicles) at room temperature, vortexed briefly, and sonicated for 30 seconds.
The combined solution was then frozen to -20°C, thawed at room temperature, and
sonicated for 30 seconds. The freeze-thaw-sonication process was then repeated for a
total of three cycles. The protein:lipid ratio was 1:10 in the new mixed vesicles with
an internal buffer concentration reduced to fifty percent of the original concentration.
Prior to experimental use the vesicles were sonicated and vesicle diameter measured
by DLS.
Proton Flux Assay
Proton flux across the vesicle membrane was measured by the method
described by Cao, et al. (33) and Franklin, et al (34). The translocation buffer for
experiments at pH 7 was composed of 190 mM Na2SO4, 0.1 mM KH2PO4 and 0.1 mM
K2HPO4 and, for experiments at pH 5.4, of 190 mM Na2SO4, 0.1 mM K3citrate and
0.1 mM KH2citrate.
Three milliliters of the translocation buffer were placed in the experimental
cuvette and stirred to equilibrate the buffer at room temperature. A highly selective
pH probe (AccupHast combination electrode model 13-620-297, Fisher Scientific,
Hampton, NH) was inserted. A solution containing 30 µL of M2 mixed vesicles was
next added to the cuvette and allowed to equilibrate for approximately 5 minutes at
room temperature (~23˚C) and changes in pH over time were recorded. After the
baseline was stable for 2 - 3 minutes, 3 µL of the K+ ionophore valinomycin (25 µg/ml
ethyl alcohol, Sigma, Saint Louis, MO) were added to the solution. After 3 - 5
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minutes, 7.5 µL of the protonophore carbonyl cyanide m-chlorophenylhydrazone
(CCCP, 200uM in ethyl alcohol, Sigma, Saint Louis, MO), were added (Figure 2-2).
Finally the solution was back-titrated after 3 - 5 minutes with 30 µL of 1 mM HCL.
During the whole process the solution was constantly stirred while continuous pH
readings were recorded. The concentration of valinomycin is not rate-limiting as
changing its concentration did not significantly change the results. Inhibitor studies
were performed in the presence of amantadine by adding 30 µL of 100 mM
amantadine to a final concentration of 1 mM and then incubating the M2 mixed
vesicles for five minutes prior to triggering proton translocation. The same procedure
was followed to detect the change in the proton flux, namely addition of valinomycin
followed by CCCP, and the standard back-titration.
To ensure the stability and integrity of the liposomes, control experiments with
valinomycin added after 5 minutes, 15 minutes, and 45 minutes of the liposomes
additions were conducted. Control liposomes were prepared in parallel without M2.
Average vesicle diameter ranged from 173-218 nm, independent of protein content.
Each M2 proton flux was measured with a control experiment under similar
conditions.
The analog output of the pH meter was filtered at 20 Hz and amplified 200
times (model LPF-8, Warner Instrument Corp, Hamden, CT).

The data were

collected and stored at 100 Hz using LabVIEW software (version 7.0, National
Instruments Corp, Austin, TX). In Excel the data were then average at 4 Hz. The data
had a relative accuracy of 0.0002 pH units with a time resolution of less than one
second. All tracings are scaled to the back-titration of 30 nmoles HCl done after each
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experiment. Drift was subtracted out of each tracing to make the change in slope after
valinomycin addition clearer.
Calculation of Single Channel Proton Flux
The time-average proton flux of a single channel was calculated from the
initial rate of hydrogen influx, converted to current, and normalized to reflect both the
extravesicular buffer strength using the back titration and the predicted number of
functional M2 tetramers assuming full incorporation and tetramerization:

i = J 0,norm / N (Tetramers)

(1

The initial rate of hydrogen influx was measured experimentally from the
initial slope of the pH curve after valinomycin addition and was taken as an average of
the steepest and the shallowest lines that could reasonably approximate the slope,
which was then converted to hydrogen influx (moles/sec) based on the standard backtitration. A typical trace is shown in Figure 2-3. Based upon the total lipid and
protein weight, the average surface area of a lipid molecule and the surface area of
lipid vesicle, the number of M2 channels per vesicles can be calculated (Table 2-1).
Vesicles that contain no or inactive M2 make up the CCCP signal and do not
contribute to the initial valinomycin pH rise. The flux can be converted to
conductance if the hydrogen driving potential is known. The solution inside the
vesicles contains 150 mM K+ and the outside contains about 0.2 mM K+ after the
addition of 30 µL of the vesicle solution to 3 mL translocation buffer. After the
addition of valinomycin, the vesicle membrane is estimated to be initially clamped at a
potential of approximately -112 mV. The time-averaged single channel conductance
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and the single channel permeability were calculated for the initial symmetrical proton
concentration conditions from:

γ = i / Vm
P=

(2

RT
γ
( Fz ) 2 [ion]

(3

The standard deviations are reported for all measurements. These
experimental standard deviations are perpetuated, in the form of variances, to
calculations of current and permeability using the following equation:
∂F ( x, y )
var F ( x, y ) =
∂x

2

∂F ( x, y )
var( x) +
∂y

2

var( y )

(4

There were five protein-free controls pH 5.4 and four and pH 7.0. There were
three M2 experiments at both pHs. There were two amantadine experiments at pH
5.4 and three at pH 7.0.
Numerical Simulation of Proton Uptake
Changes in external pH, internal pH, and membrane potential were simulated
by numerical integration using the approach given in the Appendix. This traditional
compartmental analysis represented the systems as two compartments, interior and
exterior, separated by a membrane permeable to H+ and K+. The membrane potential
is established from the equivalent circuit equation with selective permeability
represented as selective conductance. Buffers were assumed to be in instantaneous
equilibrium throughout both compartments and membrane permeability was assumed
to be low enough relative to bulk diffusion to prevent concentration gradients in
compartmental bulk solutions. Unless specified otherwise, the parameters used in the
simulations were (aggregate) GH = 0.000146 S (t = 0-5 min) and GH = 0.00146 S (t =
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5-10 min, Figure 2-7a-c only), GK=0.00146 S (t = 0-10 min), [K+]i = 140 mM, [K+]o =
1.285 mM, pHi = pHo = 6.8, buffer pK = 7.0, [Buffer]i = 120 mM, [Buffer]o = 1.188
mM, trapped volume = 2.2 µl.
Results
M2 induced pH change
Our objective was to determine the proton permeation and amantadine
sensitivity of the M2 protein at pH 7 and pH 5 in lipid vesicles. Previous researchers
have induced proton flux into vesicles via an electrochemical gradient (1,34). The
proton flux at such low concentrations of hydrogen is very minute. Using an assay
similar to Franklin et al. (34), we directly measured the basification of a weakly
buffered external solution when proton flux through M2 (reconstituted in lipid vesicles
loaded with potassium) was induced by the addition of the potassium ionophore
valinomycin.
Figure 2-2 shows the mechanism of proton transport across vesicles.
Potassium efflux creates a potential of -112 mV inside the vesicles. This potential
drives proton influx into vesicles with functional M2. The proton influx is recorded
by measuring the increase in pH of the solution outside the vesicles. Proton influx
was not detected in protein-free control vesicles. We did observe a small pH drift in
some experiments, presumably due to buffer pK shifts or CO2 solubility related to
thermal equilibration, which has been subtracted from all tracings presented for
clarity. Addition of the protonophore CCCP serves as a positive control for the
presence of vesicles without active protein.
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There is a clear increase in M2-mediated proton uptake as measured directly
under neutral pH conditions using this method. Figure 2-3 shows a typical pH 7 result
of pH change owing to proton translocation by M2. The fast rise in pH immediately
after valinomycin addition in the vesicles containing M2 is due to proton movement in
response to valinomycin induced K+ efflux. This fast signal is not observed in control
vesicles. The 10 second slope after initial addition of valinomycin is proportional to
H+ influx. This figure also shows the pH rise after CCCP addition with both M2 and
control vesicles. This is due to the exchange of K+ for H+ in all vesicles that do not
contain M2. The total signal is a combination of the valinomycin and CCCP signal
which is proportional to the total volume entrapped inside the vesicles. Figure 2-3
also shows the effect of external amantadine on M2-induced proton flux. Consistent
with amantadine block, the valinomycin signal is reduced indicating the reduction of
M2-induced proton flux. Control vesicles treated with 1 mM external amantadine
showed no amantadine induced leak at pH 7 (data not shown).
Experiments at low pH also verify the fact that M2 does not conduct
significant numbers of Na+ or K+ ions but does conduct H+. Figure 2-4 shows the
proton flux measurements at pH 5.4 using a citrate buffer. There is a detectable rise
(proton flux) after addition of valinomycin in the M2 samples. The CCCP signal is
similar to that seen at pH 7. The results with external amantadine show that the
inhibitory strength of amantadine is decreased at low pH, as the difference in proton
flux with amantadine and without amantadine is not very high.
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Analysis of Vesicle Proton Flux
Proton flux through the M2 ion channel was calculated from changes in
external pH on the basis of the rate of change in the external free hydrogen [H+]
(calibrated as deduced from the back titration and the nominal number of tetramers in
the experiment (Table 2-1). The average sizes of control vesicles, determined by
dynamic light scattering, are not significantly different from those of M2-containing
vesicles. The buffer capacities were similar for the two pH conditions, with the initial
pH being 0.2 pH units below the buffer pK in each case.
Assuming a surface area of 63 A2/phospholipid headgroup and the average
vesicle diameters listed in Table 2-1, there were 5 - 8 x 1011 vesicles in the
experimental samples, corresponding to a trapped volume of 2.2 - 2.8 µl. The amount
of total protein used at pH 5.4 was 40.5 µg, while at pH 7.0 the total protein was 15
µg. Assuming that all of the protein was incorporated and in the tetramer
configuration (functional), there were 1050 channels per average-sized vesicle in the
pH 5.4 experiments and 250 in the pH 7.0 experiments. Table 2-1 shows that
changing the pH from 5.4 to 7.0 has no significant effect in number of
protons/tetramer/second.
A high concentration of amantadine (1 mM) was used to maximally quench
M2 activity. Figure 2-3 shows that amantadine reduced the initial proton translocation
rate, as quantified in Table 2-1. We see a 49±38 % reduction of M2 proton flux in the
presence of amantadine at pH 7 (0.50 vs. 0.26 protons/tetramer-s). At pH 5.4 the
amantadine sensitivity is reduced by 12 ±93% (0.24 vs. 0.21 protons/tetramer-s).
Amantadine is known to block exclusively from the N-terminal side (4). Presuming
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the orientation of the protein to be random in lipid vesicles, we only expect fifty
percent orientated to each side and therefore a fifty percent block of proton
conductance.
To calculate the single channel conductance, we divided the difference
between the total proton influx per vesicle (determined from the back-titrationnormalized external pH initial slope and the number of vesicles in the experiment) and
that in the control experiment (due to a small amount of proton leakage through the
bilayer), by the nominal number of channels in a single vesicle. At pH 7, the total
proton influx into M2 containing vesicles after the addition of valinomycin was 124 ±
63 H+/vesicle/second. Adjusting for number of channels (tetramers) and the
membrane potential, this total influx gives a hydrogen flux of 0.50 ± 0.29
protons/tetramer-sec corresponds to a time-averaged single channel conductance of
0.72 ± 0.42 aS. At pH 5.4 these values are 257 ± 122 H+/vesicle/second, 0.24 ± 0.14
H+/tetramer/sec, and 0.35 ± 0.20 aS. The parameters for lipid vesicles are shown in
Table 2-1. The proton permeability of M2 at pH 7 and 5.4 are 191±111 x1017 cm3/s
and 2.3±1.3 x1017 cm3/s, respectively. These values are approximately 1000 times
smaller than proton conductance by gramicidin. As calculated below, M2 has an open
probability, PO, on the order of 0.001. The gating of M2 may account for the low
permeability determined here.
Selectivity of M2
The rise in pH after addition of valinomycin (the valinomycin signal) is
inherently dependant on the maintenance of a potassium gradient. If the lipid
membrane or M2 channels were to leak potassium, it would confound our studies. To
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examine the leak of potassium through M2, we stirred the vesicles for 5, 15, or 45
minutes prior to the addition of valinomycin (Figure 2-5). The five minute prevalinomycin stir time is standard for all experiments, allowing the reaction conditions
to stabilize. The 15 minute stir shows a CCCP signal that is 13% reduced when
compared to the 5 minute stir. Consistent with this observation, the 45 minute stirs
show a 34% reduced CCCP signal. Protein-free control vesicles showed that even
after 45 minutes the vesicles were stable, demonstrating that the lipid bilayers were
tight enough to maintain the K+ gradients. In contrast, introduction of valinomycin
elicited an immediate pH increase. Clearly, valinomycin enabled the K+ efflux
necessary to drive proton flux through M2.
As a test of the degree of selectivity implied by the existence of a valinomycin
signal, experiments were also performed with gramicidin, a known H+-, Na+- and K+permeable channel. At a low gramicidin surface density (0.5 µg/mL), gramicidin
exhibited proton flux into vesicles (Figure 2-6), presumably because the H+
permeability is relatively high and the K+ gradient was retained on the 5 min time
scale. At higher densities, gramicidin eliminated the CCCP signal, presumably by
leaking potassium from the vesicles. Of additional interest is the fact that, while using
the same method of preparation, namely a 3X-freeze-thaw-sonication fusion of
channel-containing and channel-free vesicles, the product shows a homogenous
distribution of the channel, demonstrating vesicle fusion is essentially quantitative. At
high concentrations of gramicidin, the CCCP signal is greatly reduced, indicating that
few gramicidin-free vesicles persist after the fusion process.
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Discussion
M2-facilitated pH Change
Vesicle uptake assays are inherently complicated because of the interactions of
multiple driving forces. In the assay used here, we start with no pH gradient and with
outward K+ and inward Na+ gradients. We then add a K+ ionophore to initiate the K+
efflux, which in turn leads to a negative membrane potential. The membrane potential
drives proton influx into vesicles with M2 present, but not into tight, protein-free
vesicles, which exhibit proton influx only after addition of CCCP (a protonophore).
Using similar techniques with both valinomycin and monensin for K+ or Na+
gradients, respectively, Lin and Schroeder (1) used intravesicular pyridine
fluorescence to demonstrate that vesicle pH modification (acidification or basification)
proceeds as expected under the assumption that M2 is impermeable to Na+, K+, or
other bath ions. We have measured the proton influx directly as a decrease in
extravesicular [H+] using a proton-sensitive electrode.
To help interpret the time course of pH changes, we simulated the flux through
an ensemble of vesicles with total trapped volume, V, each containing H+ and K+
conductance pathways, using numerical integration to solve a system of buffer,
equivalent circuit, and flux equations (see Appendix). The equations describe the
relaxation of a system perturbed away from Donnan equilibrium at t = 0. Because
there are two permeable ions, the system returns to Donnan equilibrium, a state in
which the Nernst potential for both ions equals the membrane potential, with a time
course that depends on changes in ion content inside and outside the vesicles as a
result of ion flux down electrochemical gradients. The equations neglect osmotic
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effects, which are expected to be small because ion exchange is essentially obligate.
This analysis demonstrates that one cannot determine the degree to which protons are
more permeable than Na+ or K+ ions in such assays, and gives a clearer idea of the
time course of the driving forces on the protons, so we present the results here to
provide a context for our subsequent interpretations.
Our analysis assumes a set of conditions that are fairly typical and consistent
with our experimental conditions. Namely, the solute concentrations were those used
in our experiments, that the aggregate H+ conductance was 2x10-4 S (similar to that
observed in a typical experiment with 2x1014 channels conducting 0.50 ± 0.29 protons
per tetramer per second for an aggregate proton conductance of 1.46x10-4 S), that pH
= pK-0.2 inside and outside the vesicles, and that at time 0 the K+ conductance was
increased by addition of valinomycin to 2x10-3 S, with no other ions permeant. The
calculated time courses of the change in free internal and external [H+] are shown in
Figure 2-7a. After increasing H+ conductance at t = 5 minutes, the external [H+] drops
slightly over the course of about one minute, whereas the internal [H+] rises nearly 2
pH units over the same time course. We note that, in our experiments, even the high
concentration of buffer inside the vesicles is still insufficient to hold the internal pH
constant in the face of the large proton influx, even though buffering was assumed to
be instantaneous. This is because, even with the high buffer concentrations used here,
the K+ content of the vesicles, which contain only a small fraction of the total volume,
exceeds the buffered H+. Nevertheless, the change in external pH is readily
measurable.
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Relaxation to the Donnan Equilibrium is attained after ~1 minutes. This is
demonstrated (Figure 2-7b) by the time dependence of the Nernst potentials for K+,
(EK), H+ (EH,), and the membrane potential Vm under the same conditions as in Figure
2-7a, all of which merge at the equilibrium point. In Figure 2-7c, the time course of
the external pH is amplified to show that the slow rise obtained due to the GH from M2
alone gives way to a rapid rise if additional H+ transporters, such as CCCP, are added
to the system.
Additional analysis with this simple mathematical model allowed us to
determine the following properties of the experimental system:
1. The initial slope of the change of external [H+] vs. time is proportional to GH,
as long as GH < 10 GK (Figure 2-7d). After normalizing for buffer capacity (via
the back-titration results), the time-average single channel current times the
number of channels, i.e. GH, is obtained directly from the initial slope as
expected.
2. For greater values of GH (or lesser values of GK), the initial rate of rise is
additionally dependent on GK, being proportional to GK when GK is rate
limiting (data not shown). Also, the rate of rise in pHo varied dramatically if
the initial pH - pK is changed. Variations of the initial pHo from the buffer pK
are automatically compensated when one normalizes small external pH
changes using a back-titration, but they could easily lead to factor of 5 or
higher errors in the initial slope if not properly accounted for by the back
titration.
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3. The external pH reached a plateau when the membrane potential reached a
constant value, corresponding to the establishment of Donnan equilibrium.
4. The height of the pH signal change depended strongly on the vesicular
(trapped) volume (Figure 2-7e) and the inside and outside buffer
concentrations (data not shown), but not discernibly on GH.
5. Whether the equilibrium membrane potential is nearer to the initial VH or the
initial VK depends primarily on the relative internal concentrations of buffered
H+ and K+ (data not shown). Namely, it is closer to VH if there is more
buffered H+ inside and closer to VK if there is more K+ inside. In the conditions
used in our experiments, Vm

-100 mV (Figure 2-7b).

One might wonder what happens if the membrane is permeable both to H+ and
K+ at the outset (i.e. if the M2 channel is imperfectly selective), say for PH > PK.
Although one might expect the driving force on protons to be small because the
membrane potential approaches VH, the electroneutrality-required obligate exchange
still causes proton uptake under an outwardly directed K+ gradient. If the internal free
buffer content is less than the internal K+ excess (relative to external K+), a [H+]
gradient will still develop and VH and VM will settle near to the original VK once the
Donnan equilibrium is achieved. The kinetics of the relaxation in pH and VM are
governed by the K+ flux, and hence by the PK rather than the direct electrochemical
driving force on H+. This argument justifies the conclusions of Lin and Schroeder (1)
concerning high M2 selectivity.
The argument does not apply directly to electrophysiological voltage clamp
studies (e.g. Chizhmakov et al., (4)). To the extent that the cytoplasm pH and [Na+]
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are well buffered by the patch-clamp pipette, the cell will not relax to a Donnan
equilibrium. However, it does raise some questions about the extent and timing of Na+
contamination of the very small volumes in the cytoplasm and patch pipette, which
conceivably may become sufficient to produce an artifactually high apparent
selectivity for H+ over Na+.
At the same time, the simulations help explain why gramicidin A, which is
known to have a finite permeability to K+ and Na+ (around one-tenth that of H+) can
still yield a valinomycin signal on the several-minute time scale of our experiments. If
permeability to H+ exceeds that to the metal ion, the initial driving force on H+ is low.
However, if the internal K+ content exceeds the internal buffered H+, electroneutralityrequired exchanges of H+ for K+ drive H+ into the vesicle until the internal buffer is
overwhelmed, and a valinomycin signal is observable.
Quantitative Comparison to Previous Results
Lin and Schroeder (1) reported 7.3 protons per tetramer per second at pH 7.4
and a single channel conductance of 8 x 10-18 S (at 18 C), about 10X higher than our
results . In our experiments, we took the initial slope from the 10 second interval
starting 3 seconds after the addition of valinomycin. The initial jump (first 3 seconds)
was ignored as an artifact of solvent addition rather than vesicle uptake. Lin and
Schroeder do not mention any solvent artifact, but in the published figures there is a
sharp discontinuity in slope during the first second and the second and subsequent
seconds. The shape of the approach to equilibrium in our simulations (Figure 2-7c) is
roughly that of an exponential, so it is clear that the relevant initial slope is that of the
segment leading up to the Donnan plateau. Perhaps they focused on an earlier section
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of the relaxation curve, and thus obtained a slope biased towards a higher value. This
could explain why we estimate the time-average single channel conductance and
permeability to be lower, 7.2 x 10-19 S at pH 7.0 at 22 C. Alternatively, our protein
may be less active (incorporated or well-configured) than their’s. It is not possible
from the current data to distinguish between these possibilities.
If one could make assumptions about the impact of pH on single channel
conductance (via mass action) and acid-gating, it would now be possible to relate this
to the measured single channel conductance of the open state, ~6 pS for this same
preparation at pH 3 in planar bilayers (9). For instance, we could assume that the
conductance of the open state is proportional to [H+] (with no saturation) and ignore
any acid gating effects to extrapolate an open state conductance at pH 6.8 of 0.95 fS.
By comparison to the measured time-average conductance of 0.72 aS, we would
deduce that Po = 7.7x10-4, one order of magnitude larger than that observed in the
planar bilayers (assuming that each experiment resulted from the fusion of one vesicle
containing the nominal number of fully active tetramers), i.e. 7.5x10-5 (9). However,
the acid-gating phenomenon has been well-established in electrophysiological
experiments (4), saturation is known to occur below pH 8.5 (4,9), and the vesicle
uptake results do not confirm the expectation of mass action, which point we discuss
next.
Acid-activation
From cell acidification (2), electrophysiological (4,30), and vesicle
acidification (1) experiments, it is frequently stated that M2 is acid-gated. Solid state
NMR measurements of the titration states of a peptide consisting of the
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transmembrane domain from M2 (39) indicate that two of the four His residues in the
selectivity filter are protonated with a pKa of 8.2, the third is protonated at pH 6.3, and
the fourth is protonated at pH < 5. This indicates that it is the third His37 protonation
that correlates with acid-gating in electrophysiological (4,7) and fluorescence (12,40)
studies. Care has to be exercised in the interpretation of the effects of acidification on
hydrogen conductance to distinguish the effects of mass action (passive
electrodiffusion) from effects attributable to changes in protein conformation or
dynamics. Nevertheless, a secure claim for acid-gating can be found in the result that
basification of the extracellular fluid decreases outward H+ current through M2
channels in spite of an increased outward electrochemical driving force (2,4). The
effect seems to be greatest when the N-terminus of M2 is exposed to the more basic
solution, although some effect is seen in both directions (5).
In this regard, we were somewhat surprised that our measured H+ single
channel permeabilities were not increased dramatically at lower pH. Lin and
Schroeder (1) observed a 2-fold increase in flux at pH 5.7 (compared to pH 7.4) and
we observed a slight decrease at pH 5.4 (compared to pH 6.8). However, we expect
H+ influx to be increased at the lower pHs in both cases by a factor of 25 - 50 due to
mass action, and by some additional factor because of acid gating. This lack of mass
action and acid activation occurs in both studies, although they differ in protein
species (Weybridge vs. Udorn), lipid membrane compositions, and palmitoylation and
phosphorylation states of the protein (with Lin and Schroeder using the Trichoplusia
ni insect cell expression in contrast to our usage of the E. coli bacterial expression
system). Changes in pH over a about the same range typically lead to a ~10-fold
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increase in proton conductance in electrophysiological studies with cell expression
systems (e.g. (4)). Taken at face value, one could conclude that lipid protein
interactions or conformational history causes different behavior in purified
reconstituted systems and cell expression systems.
The observation that proton channels and transporters could have a constant H+
flux over a large range of H+ bulk concentrations has been noted in other systems.
Many studies with proton transporters (41) suggest that proton transport is pHindependent in physiological conditions. For instance, Feniouk et al. (42) recently
measured proton conductance for FO in chloroplasts, finding it to have a weak
dependence on pH and a higher unitary conductance than expected from gramicidin
measurements. They attributed these behaviors to proton buffering by protein side
chains along the transport pathway. In this case residues near or in the selectivity
filter may have a buffering role. Similar behavior is shown at near-neutral pH by
proteins that form channels as summarized in DeCoursey (41). One might consider
that the pH near the mouth of the channel is buffered by the lipid head group region or
that the kinetics of proton approach to the channel are modulated by bulk buffer (43).
We suppose that in our experiments an obligatory site in the transport pathway is
saturated by pH 7.0 whose H+ dissociation rate constant is approximately the same at
pH 5.4 as at 7.0. It is possible that acid-activation may occur above pH 7.0 or below
5.4.
M2 Variants
In addition to those data shown, we have conducted preliminary proton flux
studies with various mutants of M2, including one with the His6 tag used for
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purification in either the N-terminal or C-terminal positions, without the His6 tag
(TEV-cleaved), and with fluorination of Trp41. All show similar signals indicating
that these mutated samples also primarily conduct protons and that the proton flux is
not affected by these mutations. Proton flux studies with reconstituted Udorn M2
provided by Dr. Larry Pinto’s group and reconstituted Weybridge M2 provided by Dr.
Alan Hay’s group have also been studied in our lab with similar flux results. From
these results, it appears that the quality of the incorporation and the level of
functionality are similar for all three preparations.
Amantadine Block
Preincubation of the sample with 1 mM extravesicular amantadine resulted in a
lower initial slope after addition of valinomycin, which corresponds to a final flux of
0.26 ± 0.12 protons per tetramer per second at pH 7.0 and 0.21 ± 0.19 protons per
tetramer per second at pH 5.4. These equate to a single channel conductance of 0.37 ±
0.17 aS and 0.31 ± 0.28 aS, respectively. Thus, M2 is inhibited 49 ± 38% at pH 7.0
and 12 ± 93% at pH 5.4. Although the M2 affinity for amantadine is known to be 10
µM (30) we chose to use 1 mM to obtain maximal bl7ock. At such high
concentrations of amantadine, we expected 100% block of M2 for those channels with
the N-terminus of the monomers projecting out of the vesicles (4). Lin and Schroeder
established that M2 in their preparations was randomly oriented such that half of the
N-termini were inside and half outside. Assuming that the M2 tetramers in our
proteoliposomes are also randomly oriented, we expect proton flow to be inhibited by
50% as we observed. The degree of block was reduced at pH 5, as expected from
electrophysiological experiments where Ki increases ~50% upon change in pH from
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7.5 to 6.2 for Udorn M2 (30). This reduction is not due to titration of amantadine,
which has a pKa of 10.1 and should be fully protonated at both pH 5.4 and 7.0.
Selectivity of M2
Lin and Schroeder estimated, based on the lack of baseline drift and contrary
ionophore signal, that M2 was essentially perfectly selective for protons in the
presence of high concentrations of potassium. We evaluated this conclusion in our
system by stirring the proteoliposomes for 5, 15, or 45 minutes prior to addition of
valinomycin (Figure 2-5). The 15 minute stir showed a 13% reduction in total signal
compared to the 5 minute stirand provides evidence that, on the relevant time scale (10
minutes), the vesicles remain relatively selective against potassium.
A 34% reduction in total signal after stirring for 45 minutes compared to 5
minutes was also observed at pH 7. Protein-free liposomes did not show reduced
signal even after a 45 minute pre-valinomycin stir (data not shown). This suggests
that, in addition to protons, M2 also transports other ions, including potassium.
Assuming that all vesicles in the experiment represented in Figure 2-5 lost 34% of
their membrane potential driving force, due to a reduction in VK, over 40 minutes, we
estimate that the K+ influx over the 40 minute period was 0.25 ions/tetramer/second.
The K+ flux is equivalent to a permeability of 8 x 10-23 cm3/second. Comparing
permeabilities, M2 is selective for H+ over K+ by a factor of ~107.
To examine the dependence of our assay on the selectivity of M2, experiments
were also performed with gramicidin A (Figure 2-6), which is selective for H+ over K+
by a factor of ~10 (44). In our experiments, when gramicidin was reconstituted into
liposomes at concentrations of 50 - 500 ng/mL, the entire potassium gradient
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(membrane potential) was lost after only 5 minute incubation and stirring in the low
K+ buffer. At the lower dose of gramicidin (5 ng/mL) the proton influx is similar to
that observed with M2, indicating that even with a moderate amount of nonselective
leakage, preservation of a significant portion of the potassium gradient over 10
minutes is possible.
Incorporation, Tetramerization, and Open State Probability
We do not yet have a good measure of incorporation and tetramerization for
M2 reconstituted into vesicles, but preliminary evidence from NMR studies indicate
that protein incorporation is variable and incomplete under conditions used to date.
However, to provide upper limits, we will continue the assumption of complete
incorporation used previously, extending it as well to gramicidin A incorporation, and
examine how the slope in the M2 signal compares to that of the gramicidin A signal.
At 5 ng gramicidin A/mL there are approximately 6 gramicidin monomers per
vesicle or 8 x 10-11 mol cm-2. Assuming the dimerization constant determined with
dansylated gramicidin fluorescence studies (K = 2 x 1013 mol-1 cm2 in painted
dioleoylphosphatidylcholine bilayers, (45), at this concentration the equilibrium is
heavily biased (99%) towards dimers, yielding 3 dimers per vesicle. For M2, the
tetramer

dimer dissociation constant was measured with analytical centrifugation

(46) to be 4x10-21 M. To determine the fraction of tetramers in our experiments based
on the Kochendoerfer et al. model (46), we compared the lipid concentration (15 mM)
and the M2 monomer (MW 11,250) concentration (e.g. 0.09 mM at pH 7), to those of
the concentrations of detergent (15 mM dodecylphospho-choline) and M2 protein
(covering a range) in the Kochendoerfer et al. (46) micelle preparation. According to
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their model analysis, the tetramer would comprise a protein weight fraction of ~0.9,
with a fraction of ~0.1 containing monomers and octamers at our protein density.
Hence, for a typical vesicle at pH 6.8, 90% of the mass or 222 tetramers per vesicle
would be in the tetramer state. Qualitatively, it appears that the initial H+ flux with 5
ng/ml gramicidin A, corresponding to 3 channels/vesicle (Figure 2-6), is similar to that
with M2, suggesting that gramicidin A is 74x more active than M2. The single channel
conductances for the two channels are similar at lower pH (9), so we attribute the
higher activity of gramicidin to a higher probability that the dimer channel is open, i.e.
in the conducting state. On this basis, if for the conditions of peptide density used
here, the Po for the gramicidin dimer is 1.0, we estimate the Po for the M2 tetramer to
be 0.014, similar to values estimated from single channel conductance studies (9).
In summary, the proton flux assay has the potential to provide very sensitive
and accurate measurements of M2 channel activity. The present work reports our first
attempts to measure proton flux through the M2 protein reconstituted into lipid
vesicles. There are many parameters that are yet to be studied, such as dose response
curves for M2 and amantadine, internalization of amantadine, reconstituting M2 by
various methods such as dialysis, more thoroughly measuring proton flux with
changes in pH for studying acid activation and His37 titration, and evaluation of M2
protein orientation in smaller vesicles. Future research will lead to finer control of
these variables.
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Appendix
We assumed that buffer equilibration was instantaneous on the time scale of
membrane flux. The analytical solution to the differential equation was assumed to be
too difficult to obtain due to the contributions of driving forces for two ions, one being
buffered according to:
HP ↔ H + + P −
Kd =

(A1

[ H + ][ P − ]
[ HP]

The algorithm used was:
A. From the initial pH, inside and outside of the vesicles, the initial total [H] =
[H+] + [HP] (i.e. free hydrogen plus hydrogen buffered by phosphate) is first
calculated from the free H+, [H+], and the total buffer (phosphate) concentrations, [P],
on each side. For this, Equation A1 is converted to a quadratic equation in [H+] with
only [P] and [H] as parameters by substituting [H+]-[H]+[P] for [P-] (the unprotonated
buffer) and [H]-[H+] for [HP], both based on conservation of matter, into equation A1
to obtain:

[ H + ]2 + ([ P] − [ H ] + K d )[ H + ] − K d [ H ] = 0

(A2

Solving (A2) for [H],
[H ] =

K d + [ H + ] + [ P]
K
1 + d+
[H ]

(A3

Because the first two terms of the numerator are negligible, the bound and free
proton concentrations comprise approximately one half the total buffer concentration
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when pH=pK, as expected. This equation allows us to explore conditions where
pH pK.
B. The initial membrane potential is computed for selected conductance
parameters using the equivalent circuit equation, with the assumption that only H+ and
K+ are permeant, and computing the Nernst potentials, EH and EK, from the initial
concentrations inside and outside of the vesicles:

Vm =

GH E H + GK E K
GH + GK

(A4

C. The flux for each species, in moles per second, is taken from the ionic
current using the same conductance and driving force parameters:

J=

GS
(Vm − ES ), S = H + or K+
F

(A5

D. The change in total concentration for each ion on each side in a short time,
t, is taken as

∆[ S ] =

J∆t
, S = H + or K+
V

(A6

where the sign of the change depends on the direction of flux, and V is the
volume of the compartment being calculated, intra- or extra-vesicular. The time step
must be small enough to allow only an incremental change in ion concentrations on
each side.
E. Finally, the new free H+ concentration is computed in each compartment,
assuming instantaneous buffer equilibration, from the new [H] inside and outside
using the rational solution of equation A2, namely:
1

[ H + ] = (− A + ( A 2 + 4 K d [ H ]) 2 ) / 2

(A7
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where A = [ P ] − [ H ] + K d
This algorithm was then iterated repeatedly until a steady state was achieved. The
initial point was taken as the time of addition of valinomycin to create GK > 0,
assuming a preexisting GH > 0 via M2 channels.
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Figure 2-1 – SDS-PAGE of Reconstituted M2. Lane 1 - the apparent molecular
weights (kDa) of a standard ladder. Lane 2 - M2 reconstituted in vesicles
(DMPC:DMPG 4:1) is free of contaminants. Lane 3 - Application of trypsin to
proteoliposomes cleaves M2.
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Figure 2-2 – Proton Flux Assay. Proton flux is driven by a membrane potential
created when valinomycin is added to vesicles prepared with asymmetric [K+].
Valinomycin, a potassium ionophore, allows potassium efflux, creating the potential
that drives proton influx through M2 protein. Proton-leaky vesicles without M2 also
will exhibit flux at this step. CCCP, a protonophore, permits proton influx into
vesicles that did not previously discharge their gradient. The pH stabilizes after
addition of valinomycin when vesicles reach the Donnan equilibrium for hydrogen and
potassium. Activity of K+ was determined as described in methods.
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30 nmoles H+

No Protein
2 minutes

M2
Amantadine

Figure 2-3 – M2 Proton Flux at pH 7.0. Representative tracings of proton flux into
vesicles: A) Protein-free vesicles show no change in slope after addition of
valinomycin confirming that these vesicles do not leak protons. Addition of
valinomycin is indicated by the arrow and addition of CCCP is marked by the
arrowhead. The presence of a CCCP signal shows the influx of protons into control
vesicles. B) Vesicles containing M2 show increased proton influx after addition of
valinomycin. C) This proton influx can be reduced by pre-incubating M2 vesicles
with amantadine.
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No Protein

2 minutes

M2

Amantadine

Figure 2-4 – M2 Proton Flux at pH 5.4. Representative tracings of proton flux into
vesicles: A) Protein-free control vesicles show no change in slope after addition of
valinomycin. A second addition of valinomycin seemed to cause a little artifact in
control vesicles. B) M2 increased proton influx after addition of valinomycin. C)
Amantadine block is less effective at pH 5.4. The meaning of arrows and arrowheads
is the same as in Figure 2-3.
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30 nmoles H+

5 Minutes
2 minutes

15 Minutes

45 Minutes

Figure 2-5 – Time Series. Vesicles were stirred for 5, 15, or 45 minutes prior to the
addition of valinomycin. A) 5 minute pre-valinomycin stir is our normal protocol. B)
15 minute pre-valinomycin stir showed a 13% reduction in total signal compared to 5
minute stir. C) 45 minute stir show a 34% reduction in the total signal compared to 5
minute stir. As the control vesicles showed no reduction even after 45 minutes, the
reduction seen in proteoliposomes is attributed to leak of potassium through M2. The
meaning of arrow and arrowhead is the same as in Figure 2-3.
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30 nmoles H+

No Protein
2 minutes

5 ng/mL

50 ng/mL

Figure 2-6 – Effect of Gramicidin on the proton flux assay. Vesicles containing
gramicidin were prepared in a manner similar to M2 containing vesicles. The final
concentration of gramicidin was 0, 5, 50, or 500 (not shown) ng/mL. A) Protein-free
control shows no valinomycin signal. B) 5 ng/mL of gramicidin showed twice the
slope after addition of valinomycin as did control. It also shows a reduced total signal,
suggesting potassium leakage through gramicidin. C) 50 ng/mL of gramicidin was
sufficient to eliminate any response to valinomycin and CCCP. Higher concentrations
also showed no signal (not shown). The meaning of arrow and arrowhead is the same
as in Figure 2-3.
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Figure 2-7 – Theoretical prediction for the rate of establishment of Donnan
equilibrium in a system with two permeable ions. At time zero, GK is increased to
represent the addition of valinomycin; with GK=0, baseline is flat prior to this point.
The increase in GH at the midpoint is intended to represent the addition of CCCP to
stimulate the relaxation to equilibrium. a) The external (bath) pH rises slightly, while
the internal (intravesicular) pH falls rapidly, particularly after the increase in GH at t=5
min. b) Acidification of the vesicles is accompanied by a loss of driving force on H+,
as shown by the decline in the Nernst potential for H+, VH. The membrane potential,
VM, is sandwiched between VH and the Nernst potential for K+, VK. At t=5 min, VM
abandons its proximity to VK temporarily because GH is set to GK so VH contributes
more heavily to the equivalent circuit equation for VM (equation A4).
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c) Expanded view of the external pH trace on a scale similar to that used for
experimental traces. The 10x increase in GH at 5 minutes is intended to represent
CCCP addition. Differences in shape between calculated and experimental traces
could reflect membrane incorporation times for valinomycin or CCCP, which are
assumed to be instantaneous in the simulation.
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d) Increased GH results in complete Donnan equilibration in <5 minutes. The initial
slope is proportional to GH. e) The height of the valinomycin peak depends on the
trapped volume, as shown here for volumes given in µl, as well as on internal nonprotonated buffer concentration and internal [K+] (data not shown). The initial slope is
not dependent on these factors, as long as it is determined during the first 20 s after
initial ionophore addition. For this simulation, GH was set to 0.0006 S (with GK being
10x higher) to speed equilibration.
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Control
pH Out

5.4

M2
7.0

5.4

M2 + Amantadine
7.0

5.4

7.0

Potential (mV)

-112

-112

-112

-112

-112

-112

Vesicle Diameter (nm)

186 ± 28

196 ± 15

218 ± 32

174 ± 42

218 ± 32

174 ± 42

Total Lipid Surface Area (cm2)a

760

760

760

760

760

760

Total Vesicles (x10-11)

7.0 ± 0.95

6.3 ± 0.49

5.1 ± 1.5

8.0 ± 2.2

5.1 ± 1.1

8.0 ± 2.2

Total Vesicular Trapped Volume (uL)

2.4 ± 1.1

2.5 ± 0.61

2.8 ± 1.5

2.2 ± 1.7

2.8 ± 1.4

2.2 ± 1.7

Total Protein (ug)

0

0

40.5

15

40.5

15

Total Number of Tetramers

(x1014)

Tetramers/Vesicle

5.4

2.0

5.4

2.0

1050

250

1050

250

Initial Slope (mv/min)

4.0 ± 1.6

7.1 ± 2.8

27.6 ± 1.8

31.5 ± 14.3

32.4 ± 21.9

15.6 ± 0.6

Height of 30 nmol H+ back-titration (mV)

97 ± 36

128 ± 57

75 ± 36

92 ± 30

106 ± 2.0

91 ± 33

H+/Vesicle·s

21 ± 12

32 ± 22

H+/Tetramer·s

257 ± 122

124 ± 63

226 ± 197

64 ± 23

0.24 ± 0.14

0.50 ± 0.29

0.21 ± 0.19

0.26 ± 0.12

Unitary Current (A x1021)

39.1 ± 21.9

80.5 ± 46.9

34.4 ± 30.9

41.3 ± 19.0

Unitary Conductance (S x1018)

0.35 ± 0.20

0.72 ± 0.42

0.31 ± 0.28

0.37 ± 0.17

Proton Permeability (cm3/s x1017)

2.3 ± 1.3

191 ± 111

2.0 ± 1.8

9.8 ± 4.5

Table 2-1 – Calculation of Single Channel Current, Conductance, and Permeability.
a

Assuming 63 Å2 per headgroup per leaflet x 2 leaflets per bilayer.
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Chapter 3 – Determination of the Stoichiometry of DCCD Block of
Proton Flux through FO Following Deletion of an E. coli Gene
Suspected of Forming a Confounding Cation Channel
Abstract
The proton-translocating FOF1 ATPase (ATP synthase) is a member of the
ATPase protein family that bioenergetically interconvert proton motive force with the
synthesis of adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and
inorganic phosphate (Pi). FO is the membrane sector that translocates protons (H+)
across membranes, converting electrochemical energy to rotational inertia, thus
driving ATP formation in F1. Previous experiments have been partially confounded
by a contaminating channel, CL, which co-purifies with FO and leaks cations. In this
chapter CL activity is shown to not decrease following deletion of the previously
uncharacterized yraM open reading frame of E. coli. In fact, deletion of this reading
frame actually increased apparent CL activity. FO purified from a strain in which yraM
was deleted is just as active as FO purified from the wild-type strain. FO from the
deletion strain was utilized to examine the single-hit hypothesis of DCCD inhibition of
passive proton flux through FO. A DCCD-induced reduction in ATP synthase activity
correlates with a reduction in the total initial slope, the number of functional FO per µg
protein, and the single channel proton flux. The data suggest that passive proton flux
requires the addition of 2 DCCD per FO, to totally inactivate passive proton flux, while
ATP synthase activity requires 1 DCCD per FO for inactivation.
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Introduction
The FOF1 ATPase (ATP synthase) is a member of the proton-translocating
ATPase protein family that bioenergetically interconverts proton motive force (PMF)
with the synthesis of adenosine triphosphate (ATP) from adenosine diphosphate
(ADP) and inorganic phosphate (Pi). ATP synthase is vital for life in organisms from
both the plant and animal kingdoms and different members of this family of enzymes
can be found in bacterial cytoplasmic membranes, mitochondrial inner membranes,
and thylakoid membranes of chloroplasts, and archaeabacteria. ATP synthase
catalyzes the last step in oxidative metabolic pathways using a proton electrochemical
gradient to make ATP from ADP and phosphate, as postulated forty years ago by P.
Mitchell. It is noteworthy that this mechanism can run in the reverse direction so that
ATP hydrolysis can be used to pump protons up an electrochemical gradient within
cells (F-type ATPase in bacteria) or organelles (V-type ATPase in eukaryote cells).
The eukaryote F-type ATP synthase has not been shown to run in the reverse
direction.
The structure of F1FO ATPase is described in Chapter 1. The F1 sector is the
site of ATP formation or hydrolysis. Its structure and function are well known (1,2).
It is composed of three sets of

and

subunit pairs and one each of , , and . A

conformational shift in subunit alters the interactions of the
formation.

pairs, causing ATP

and are linked to the c subunit ring of FO. By labeling the subunit

Noji et al (3) demonstrated that the

subunits rotate with respect to the subunit.

FO is the proton transport sector that is embedded in the membrane and
connected to the F1 sector which sits above the membrane. FO is composed of a ring
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of c subunits, two b subunits, and one a subunit with a total molecular weight of 136
or 160 kDa if there are 9 or 12 c subunits respectively (molecular weights of a, b, and
c are 30, 17, and 8 kDa, respectively (4)). The ring of c subunits spins in the plane of
the membrane, carrying the protons through the membrane. This spinning is coupled
to the F1 sector through the subunit. Sambongi el al. have published the
visualization of the spinning of FO coupled to F1 (5). The a and b subunits are together
on the outside the c subunit ring. The functional transport of protons by FO is
sometimes compared to gramicidin (6). Although the mechanism of proton transport
is different (discontinuous water wire versus a continuous one, respectively) the
functional form of both channels are composed of two half channels. In the case of FO
both halves of the channel are in the a subunit. Protonation and subsequent rotation of
the protonated c subunit 360º around the ring forms the link between the two half
channels. Based on available structural data, Aksimentiev et al. (7) recently modeled
the interactions between the a and c subunits. The studies confirm that Asp61 of the c
subunit is the residue that is protonated during proton translocation. Using the
assumption that Ser206 in the a subunit is the termination of the cytoplasmic half
channel and that Asn214, also in the a subunit, is the termination of the periplasmic
half channel, it was shown by Aksimentiev et al. (7) that a hydrogen-bonded
intermediate was formed when two protonated c subunits are close to Arg210 of the a
subunit. The hydrogen bonding extends from Ser206 to one protonated Asp61 to
Arg210 to a second protonated Asp61 to Asn214. When only one c subunit is
protonated a strong ionic attraction occurs between Asp61 and Arg210 such that
rotation is stopped. Only when the second Asp61 is protonated is the weaker
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hydrogen bond formed, allowing for rotation of the c subunit past Arg210. The
authors proposed that this bridge is a ratchet that hinders FO from rotating in the
improper direction and that the protonation of Asp61 in both c subunits is dependent
on the concentration of protons on their respective side of the membrane. This
mechanism explains passive proton diffusion and activity as an ATP synthase, but
seems to run counter to the use of ATP to pump hydrogen up a gradient, therefore, it
may be a better model for the eukaryote F-type ATP synthase but not the larger family
of proton-transporting ATPases which can run in reverse.
The bacterial FOF1 ATPase is particularly interesting to study because it is a
true motor in the classical sense. Like an electrical generator, ATP synthase has a
rotor (c ring, and subunits) and a stator (a, b and subunits) (8). Rotation of c with
respect to a and b is then transferred to the stalk ( and ) producing conformational
changes in

and

to make ATP.

The energy that drives this molecular motor is the proton gradient that is
created by mitochondria, chloroplasts, and bacteria. Several previous studies have
calculated total proton flux through a known amount of purified FO from E. coli (after
F1 has been stripped off). Most of these have utilized FO containing liposomes where
the proton flux rate was measured while under a transmembrane potential
(9,10,11,12,13,14). Although estimates vary by a factor of 1,000 (Cao 70 H+/FO/sec,
Lill 105 H+/FO/sec), the two most recent publications vary only by a factor of 2 and
estimate the flux to be 6240 protons per second per FO (6) and 3100 protons per
second per FO (12). These calculations represent the time-averaged single channel
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conductance of FO after the F1 sector is removed. In this chapter I report the single
channel flux in a mutant strain of E. coli.
In the earlier measurements of the single channel conductance of FO, Cao et al.
(13) and Franklin et al. (12) were confounded by a contaminating protein that copurified with FO and leaked cations. Characterization of this leak-channel revealed a
cation channel named CL. The channel was characterized by Cao et al. and found to
hinder their assays since it leaks K+, eliminating the membrane potential in some of
the vesicles. To calculate the single channel conductance, our proton flux assay relies
on using the Poisson distribution to calculate the number of active FO channels per
vesicle. Since the CL channel reduces the total signal of the assay by reducing the
total number of observed vesicles, less protein must be used during vesicle preparation
to avoid adding so much CL that the total signal is completely eliminated. This
reduces the maximum proton flux, making it more difficult to detect proton flux from
background noise. Their assay is very similar to our current protocol.
In an attempt to improve the sensitivity of our proton flux assay, the gene for
CL was potentially identified and deleted by Dr. William Brusilow and co-workers.
The amino acid sequence of this purported channel matched the E. coli yraM open
reading frame (GenBank accession number AAC76181) that prior to our studies had
no known function, but was thought to be a lipoprotein, a glycosidase, or have another
unknown function. The protein is expected to have a mass of 72-73 kDa.
Quantification of proton flux through FO purified from this new deletion strain and
experimental confirmation of the deletion of CL were the aims of this chapter.

73

This new strain was then used to assay the stoichiometry of inhibition of FO by
N,N'Dicyclohexylcarbodiimide (DCCD). As this drug has been shown to inhibit FO
function (15), the ability of DCCD to block proton flux is used to confirm that the
proton flux is due solely to FO. Researchers have been examining the mechanism of
inhibition for decades and have found that DCCD inhibits ATP synthesis by
covalently binding to Asp61 on the c subunit to form an N-acyl urea (16). Asp61 is
the residue that carries the proton through the c subunit ring. Thus DCCD selectively
blocks proton transport by FO. The stoichiometry of DCCD inhibition of FO required
to block proton flux has been debated. There are two generally accepted models of
inhibition.
The first model is the single hit hypothesis which suggests that no matter how
many c-subunits constitute an active FO proton channel, it only requires one DCCD
molecule per FO to entirely inhibit proton transport. Much research from the
laboratory of R. Fillingame supports this hypothesis (17,18,19,20,21). In Hermolin
and Fillingame (19) it was shown that 1 DCCD/FO is sufficient to inhibit ATPase
activity. Using HPLC chromatography to separate the DCCD modified c subunits
from the unmodified subunits and using specific radioactivity of c subunits treated
with radioactive DCCD, they provide support for the single-hit model. Dmitriev et al.
(17) incorporated non-functional c subunits into FO and observed how the activity of
FO was affected. Using two forms of the c subunit and the assumption that the
reassembled complex was either completely functional or completely nonfunctional,
they found that it took either 1 or 2 c subunits to inactivate FO. Jones et al. (21)
showed that incorporation of one c subunit with a Asp61Gly mutation appears to
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inhibit FO activity. However mutation of Asp61 to the structurally similar, but nonprotonatable, Asn showed only reduced inhibition with incorporation of one c subunit.
The mechanism of how DCCD binding to residue 61 of the c subunit inhibits proton
flux through FO has never been clearly established, but Asp-61 is integral in the proton
flux pathway. It is likely that DCCD binding at this site prevents proton binding.
A second possible model has some support in the literature, particularly from
the laboratory of L. Ernster (22,23). It is possible that F1, when attached to FO, slows
down proton flux thereby making it easier to inhibit proton flux with DCCD than
inhibition of proton flux through FO alone. Kopecky et al. (23) also used specific
radioactivity to show that while only 1 DCCD per FOF1 complex was sufficient to
inhibit ATPase activity, 2 DCCDs per FO were required to inhibit FO when F1 was
absent. Similar results were reported by Glaser et al. (22), who created titration curves
of proton translocation coupled to ATPase activity and NADH oxidase activity of the
FOF1 complex and passive proton flux through FO alone to support their conclusions.
Two other possible results are not supported in the literature, yet are suggested
by the stoichiometry of FO. One is that DCCD simply inhibits proton flux by out
competing hydrogen at aspartate-61. Consequently, addition of more DCCD should
lead to more inhibition. The last possibility is that there is no inhibition of proton flux
until all c subunits have been hit by DCCD. This last case is not likely as there are
approximately 10 c subunits per FO. Since all the published values suggest 1 or 2
DCCD per FO, it is very unlikely that they are all off by a factor of 10.
In this chapter we examine the single-hit model of DCCD in a system that has
never been utilized before. First E. coli membranes containing the entire FOF1
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complex are treated with DCCD. The ATP synthesis activity of the membranes is
used to determine the block of FO by DCCD. Then FO is stripped from the complex
and proton flux assayed. The quantitative proton flux assay developed in our lab (12)
is ideally suited to test the single-hit model, particularly to examine whether one or
two DCCD molecules are required to inhibit FO activity. The proton flux assay we
perform is unique in that we can directly correlate the activity of individual FOs with
proton flux.
Materials and Methods
Creation of a potential CL deletion E. coli strain
The CL deletion mutant was a kind gift from William Brusilow, Ph.D. (Wayne
State University School of Medicine, Detroit, MI). Briefly, the CL deletion mutant
was constructed by following the Wanner deletion method (24). This method allows
for insertion of an antibiotic resistance gene in a chromosomal gene. A doublestranded mutagenic oligonucleotide was transformed into the Wanner strain and
allowed to recombine, replacing the antibiotic resistance, resulting in an otherwise
wild type operon with the yraM gene deleted. The deletion strain was selected for by
loss of ampicillin resistance and its identity confirmed by DNA sequencing. The
constructs were then co-transfected into an E. coli ATPase deletion strain with
ilv::Tn10 and PCR. PCR was used to screen for restoration of the unc operon.
Isolation of FO
Two tubes of 10 mL each of autoclaved LB broth were inoculated with either
E. coli containing our CL deletion or wild type E. coli. The tubes were then placed in
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a shaking incubator at 37° C. The OD (optical density) of a 1:10 dilution of bacteria
in water was measured at 600 nm hourly until the bacteria grew to a corrected OD of
5. The two tubes were then divided between four 2-liter Erlenmeyer flasks each
containing 500 mL of autoclaved LB broth and the bacteria were again incubated at 37
º C with vigorous shaking. The OD was tested hourly until the bacteria grew to an OD
of 0.8 and then the broth was tested every half hour. When the bacteria reached an
OD of ~1.5, the cells were pelleted by centrifugation for 10 minutes at 10,000 x g.
The supernatant was discarded and the pellets were removed and combined into one
pre-weighed tube and resuspended in enough Buffer 1 (containing 50 mM Tris-Cl and
10 mM MgCl2 pH 8.0) to yield 10 grams of pellet/15 mL buffer. The cells were then
ruptured by extruding them through a French Press twice at 16,000 psi. The ruptured
cells were then centrifuged for 10 minutes at 10,000 x g after which the pellet was
discarded. The supernatant was centrifuged for 60 minutes at 100,000 x g. A small
portion of the pellet was then put in MOPS-Mg solution (containing 50 mM Tris-Cl
and 10 mM MgCl2 pH 7) on which a Lowry Protein assay and ATPase assay were
later performed. The Lowry was only performed so that the specific ATPase activity
could be determined. This activity should be reduced after performing following
process to strip F1 off of the membrane bound FO.
The remaining pellet was resuspended in 25 mL of Buffer 3 (containing 1 mM
Tris-Cl, 0.5 mM EDTA, 10 % glycerol and 0.1 mM AEBSF pH 8.0). The solution
was then centrifuged for 60 minutes at 100,000 x g. After centrifugation, the
supernatant was discarded. A small measured portion of this pellet was also
suspended in 100 µl of MOPS-Mg solution for protein and ATPase assays. The
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remaining pellet was resuspended in 25 mL of Buffer 3 and centrifuged for 60 minutes
at 100,000 x g.
After centrifugation the supernatant was discarded and the pellet was
resuspended in 2 mL of buffer 7 (containing 50 mM Tris-Cl, 10 % glycerol, 0.1 mM
EDTA, 0.1 mM AEBSF, and 0.1 mM DTT pH 8.0). Deoxycholate was added to a
concentration of 0.1% and the solution was stirred for 10 minutes on ice in the dark.
The solution was then centrifuged for 60 minutes at 100,000 x g. The supernatant was
discarded and the pellet was resuspended to the same volume as before. Deoxycholate
was again added to a concentration of 0.1 % and the solution was stirred for 10
minutes on ice in the dark. The solution was then centrifuged for 60 minutes at
100,000 x g. The supernatant was discarded and the pellet was resuspended in 2 mL
of Buffer 7. A Lowry assay was then performed on this and the previously saved
aliquots.
The final FO solution was diluted until the protein concentration, as determined
in the Lowry, was ~20 mg/mL. The volume of the solution was then measured and
0.13 mL of saturated (NH4)SO4, 65 µl of 10% sodium cholate, and 95 µl of 20% octyl
glucoside were added per mL of solution. This final solution was stirred on ice for 20
minutes.
The solution was the centrifuged for 60 minutes at 100,000 x g. The
supernatant was saved and its volume measured. 0.538 mL of saturated (NH4)2SO4
was added per mL of measured supernatant. The solution was then stirred on ice for
20 minutes until a white precipitate formed. The solution was then centrifuged for 10
minutes at 12,000 x g. The supernatant was discarded and the pellet resuspended in
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0.5 mL of Buffer K (containing 10 mM Tris-Cl, 150 mM NaCl, 10% glycerol, 0.2 mM
AEBSF and 1% sodium cholate pH 8.0). A Lowry assay was performed to find out
the final protein concentration and an SDS-PAGE gel was run to verify the protein
purity. The final protein solution was stored in liquid N2 and thawed just before use.
Vesicle Preparation
Vesicles were prepared from E. coli Polar Lipid Extract (Avanti Polar Lipids,
Alabaster, AL catalog # 100600P) and 5% (wt:wt) cholesterol. The lipids were
solubilized (30 mg/mL) in Dialysis Buffer (containing 150 mM KH2PO4 and ~100
mM KOH titrated to pH 7.00 and filtered at 0.1 µm) to which 2 mM mercaptoethanol and 1.5 % octyl glucoside were added. The reducing agent and
detergent were added after filtering. The lipids were placed on a rocker at medium
speed for 3 to 4 hours to complete dissolution. The lipid solution was dialyzed (12 –
14 kDa cut off limit, Spectrum Medical Industries, Inc., Laguna Hills, CA) against 1 L
Dialysis Buffer. The lipids dialyzed for over 30 hours in a darkened cold room with
the Dialysis Buffer being changed at least twice during that period. The resulting
vesicle suspension was aliquoted and stored in liquid N2 in 1 mL aliquots.
Before use, lipids were thawed to room temperature and bath sonicated for 20
seconds three times or until translucent and optically consistent. A 1.5 mL tube was
filled with 435 l of sonicated lipid, 11 l of Triton-X 100 (to a final concentration of
2.2%, Fisher Scientific, Hampton, NH), 1.3 l of 0.25 M EDTA (to a final
concentration of 0.64 mM, Mallinckrodt Baker, Inc. Paris, KY ), protein to the desired
concentration, and Buffer K to a final volume of 500 µL. The vesicle solution was
gently shaken for 45 minutes with several 5 minute vortex steps during that period.
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The vesicles were then added to 50 mg SM-2 Adsorbent Bio-Beads (Bio-Rad
Laboratories, Hercules, CA) and gently shaken for at least 8 hours. This was repeated
two more times with 75 mg of Bio-Beads for at least 10 hours, and 150 mg of BioBeads for at least 8 hours. All quantities were scaled up proportionately for
preparations of 800 µL. The vesicles were extruded by making 21 passes through a
200 nm polycarbonate membrane mounted a Lipofast unit (Avestin, Ottawa, ON,
Canada) as described in Macdonald et al (25). Mean vesicle diameter, as verified
using dynamic light scattering (90Plus Particle Size Analyzer, Brookhaven
Instruments Corporation, Holtsville, NY) was 200 nm ± 21.5 nm. All chemicals were
from Sigma (Saint Louis, MO) unless otherwise stated.
Proton Flux Assay
The proton flux assay is based on the assay of Schneider and Altendorf (26) as
modified by Franklin (12). To measure the flux of protons, 3.84 mL of Translocation
Buffer (200 mM Na2SO4, 5 mM MgSO4, and 0.2 mM Tricine titrated to pH 7.00) was
stirred for 40-60 minutes to equilibrate temperature and CO2 in the air, thereby
reducing pH drift, until the drift was less then ~2 mV per 2 minutes as measured by a
highly sensitive micro pH electrode (AccupHast combination electrode model 13-620297, Fisher Scientific, Hampton, NH) attached to a pH meter (Mettler Toledo, model
SevenMulti, Schwaerzenbach, Switzerland) . Experiments were performed in a water
jacketed bath with vial temperature of 24.8 ± 0.8 ºC. The pH, rounded to the
thousandths place, was sampled at 2000 Hz, averaged at 4 Hz, and outputted to a
computer. Data were exported directly to Excel and saved in a back up data file.
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After recording pH from the translocation buffer alone for at least 3 minutes, 3
µL ethanol were added to measure solvent artifacts alone and data were collected for 2
minutes. Vesicles (50 µl) prepared as described were then added to the vial and data
were collected for 5 minutes; then 3 µl valinomycin (a potassium ionophore, Sigma,
Saint Louis, MO) of a 160 µg/mL stock solution (final concentration 120 ng/mL) were
added. After 5 minutes 3 µl carbonyl cyanide m-chlorophenylhydrazone (CCCP, a
protonophore, Sigma, Saint Louis, MO) of a 400 µM stock solution (final
concentration 300 nM,) were added and after 5 minutes a standard back-titration was
performed as follows: addition of 100 nmoles HCl (100 µL of 1 mM HCl), with data
collection for 2.5 minutes and a second addition of 100 µL 1 mM HCl, with data
collection for 2.5 minutes. An average experiment lasted 20 minutes from ethanol
addition to termination of the last back-titration.
Translocation buffer was stored at RT and was stable for 2 – 3 months.
Vesicles were stored in the dark at RT and were stable for one month (12).
Valinomycin and CCCP were stored at -20ºC and were stable for at least 6 months.
HCl was stored at RT and was stable for less than one month. Storage for longer
times led to a smaller back titration, decreasing our measurement of the buffer
strength. Reserve solutions of translocation buffer, valinomycin, CCCP, and HCl
were stored at -20 ºC and were stable for at least 6 months. Prior to using any
solution, it was allowed to warm completely to room temperature.
The total signal is the final height of the valinomycin plus CCCP signals
compared to what would be expected from drift alone. This height is proportional to
the trapped volume within all vesicles that did not contain CL. Determination of the
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total signal was as follows. A data trace is printed out from Excel. A straight line is
hand drawn through the signal just prior to the valinomycin peak. This line represents
the pH drift and is extrapolated forward by hand. The pH drift at the end of the CCCP
signal is extrapolated backward by hand. The total signal is then the distance between
these two lines taken at one time point, typically the addition of CCCP. The height of
the back-titrations is determined in the same manner, i.e. the difference in height
between two lines representing the pH drift before and after each addition. The x and
y axes of the printouts for all assays from the same day were done on the same scale,
i.e. the scales covered the same relative ranges not the same total range.
Results
We had two objectives: 1. to examine the effect of deletion of the E. coli gene
yraM, which is thought to be a cation-leak (CL) channel and 2. to use this new strain to
quantify the block of proton flux by DCCD. Both of these objectives can be examined
with our proton-flux assay. For the second objective we wanted to determine the
stoichiometry of inhibition of proton flux by DCCD by determining the proton
permeation of the FO sector of FOF1 ATPase.
Deletion of E. coli yraM gene product CL
The identification and deletion of the yraM gene was performed by our
collaborator William S. A. Brusilow (Wayne State School of Medicine, Detroit, MI)
as describe in the Methods section. He provided us with most of the FO purified from
the deletion and the wild-type strain. Additionally, he provided us with a colony of
wild-type and deletion E. coli for our own protein preparations, which I learned to do
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during a two-week rotation in his laboratory. Some experiments were from FO
preparations performed in our lab.
We ran a 4 - 20% polyacrylamide gel electrophoresis (PAGE) on the protein
from wild-type and deletion E. coli to confirm deletion of the yraM gene product
(Figure 3-1). The yraM gene product is expected to be about 72 kDa. There are no
consistent bands at that weight in the wild-type preparations that are not present in the
deletion preparations. Additionally, lane 4 shows a wild-type preparation with a dark
doublet at about 40 kDA. In a previous gel this preparation was compared with a
deletion preparation, which did not show the doublet, from which we had hoped CL is
the result of cleavage of the yraM gene product. However, other wild-type
preparations, as exemplified by lane 1, do not show the doublet at 40 kDa, suggesting
the doublet is not consistent with deletion of CL.
Proton Flux Assays
The protein extract was then reconstituted into lipid vesicles (at pH 7) for
analysis in our proton flux assay. Figure 2-2 (Chapter 2) shows the mechanism of
proton transport across vesicles. Following addition of valinomycin (a K+ ionophore)
potassium efflux creates a membrane potential of ~-110 mV inside the vesicles. This
potential drives proton influx into vesicles with functional FO. The proton influx is
recorded by measuring the increase in pH of the weakly buffered solution outside the
vesicles. The fast rise in pH immediately after valinomycin addition in the vesicles
containing FO is due to proton movement in response to valinomycin induced K+
efflux. Proton influx was not detected in protein-free controls after addition of
valinomycin. As demistrated in Chapter 2, the slope of the initial valinomycin signal
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is proportional to H+ influx. We did observe a small pH drift in most experiments,
which was subtracted out by setting it as a baseline for the fitting of the initial slope
(Figure 3-2). Addition of the protonophore CCCP serves as a positive control for the
presence of vesicles without functional protein, as CCCP allows the exchange of K+
for H+ in all vesicles that did not previously equilibrate K+ for H+. The total signal is
defined as the combination of the valinomycin and CCCP signal and is proportional to
the total volume entrapped inside the vesicles and depends on the buffer strength
inside the vesicles. A standard back-titration of 100 nmoles HCl serves as a
calibration for external buffer strength. CL has been shown by previous researchers
(13) to reduce the total signal by allowing potassium to leak out of some vesicles.
Figure 3-2 shows a representative trace of the proton flux assay. The vesicles
are stirred for a total of 5 minutes before the addition of valinomycin, including the
addition of 3 µl solvent 2 minutes before the valinomycin addition. The pH drift is
taken into account by averaging 45 seconds of data points to get a pre-valinomycin
slope. The post-valinomycin data are fit by a line through 10 seconds of data starting
3 seconds post-valinomycin. The true valinomycin signal is the difference of the
slopes from the pre- and post-valinomycin lines. The ethanol addition shows that
ethanol alone causes a small, fast basification of the solution, suggesting that the initial
(0-2 seconds) valinomycin signal includes an ethanol artifact.
Figure 3-3 is a close up view of the ethanol and the valinomycin additions in a
different experiment than the one visualized in Figure 3-2. The trace in Figure 3-3 is
from an experiment will less protein, so the valinomycin signal is smaller, thus
enabling easier comparison of the ethanol artifact. Care has been taken during data
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analysis to avoid including this artifact in the true proton flux signal observed during
the valinomycin signal. It required waiting for a few seconds before data could be
collected after the addition of valinomycin to not include the ethanol artifact. The
result of this is that in some experiments, particularly ones where the valinomycin
signal is not robust such as Figure 3-3, the post-valinomycin slope may be
underestimated, resulting in a lower measured flux. Future research using this assay
would benefit from elimination of the ethanol artifact by titration of the ethanol, use of
another solvent such as DMSO, or the use of curve-fitting programs to predict the true
slope.
As mentioned previously, CL reduces the total signal of the proton flux assay.
This assay can therefore be used to detect the activity of CL and other contaminants.
Figure 3-4 shows the results from proton flux assays performed on protein-free
vesicles or vesicles made with wild-type or deletion FO extract. These vesicles were
assayed on the same day and made up to the same final concentration of total protein.
The total signal is the sum of the valinomycin and the CCCP signal and was measured
as described in Methods. As expected, we observed that the deletion yielded a larger
total signal than the wild-type. However, the total signals from both vesicle
preparations were smaller than that of protein control vesicles. This initial data is
consistent with the hypothesis that the gene produce removed in the deletion strain
was partly responsible for the decrease in total signal attributed to CL.
To further quantify the reduction in total signal, the total signal from 40 assays
with protein-free controls, 35 assays using wild-type extract, and 64 assays using the
deletion extract were measured. With assistance from Center for Collaborative
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Research and Statistical Consulting at Brigham Young University, the data were
analyzed using the SAS statistical program. It was found that both protein samples
showed that the more protein added, the smaller the total signal. However, the
difference between the wild-type and deletion preparations was not significant (p <
0.25 as determined by ANOVA). Because there were some contradictory records as to
the identity of two protein preparations, these were excluded and the data reanalyzed
but the same results were obtained (not significant p < 0.21). We conclude that there
is no significant difference between the leakiness of protein extracted from the wildtype and deletion E. coli strains.
However, there is always some uncertainty in the protein concentration as
determined by the Lowry assay. Even a small global error can make a significant
difference in total flux. We are far more confident in the volume of protein aliquoted
during a particular vesicle preparation. Therefore, if we take the ratio of two protein
concentrations from vesicles made from the same protein batch, any global errors in
protein concentration will be eliminated, yielding a more accurate measure of the
increase in protein used. Figure 3-5 plots the same data discussed above but using the
ratio of the protein concentration versus the ratio of the total signal. The data were
normalized for the lowest protein concentration of all experiments from the same
protein preparation. In the event of two or more experiments at the same lowest
concentration, the data were normalized for the average of the experiments. Taking
the ratio reduced our N for wild-type to 27 and for deletion to 49. Although some
deletion experiments had a high signal at high protein concentrations, the majority had
lower ratios than wild-type. On average, the total signal fell quicker for protein from
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the deletion strain than from wild-type. Using ANOVA, this difference was
significant to a p value < 0.02. We conclude we did not eliminate CL activity by
eliminating the yraM open reading frame.
Modeling the Single-Hit Hypothesis
Previous research (22,23) has shown that while one mole of DCCD per mole
FOF1 ATPase was sufficient to maximally inhibit ATPase activity, two moles of
DCCD per mole FO were required to maximally inhibit passive proton flux. A
reduced or partial block of FO occurred at 1 mole DCCD per mole FO. In a more
recent paper Jones et al., (21) showed that incorporation of only one c subunit with the
mutation of Asp61Gly was sufficient to inhibit FO ATPase activity. However,
mutation to the more structurally related Asn required two mutations per FO to fully
block passive proton flux.
Since our proton flux assay uses, on average, less than one functional FO per
vesicle, it is ideally suited to study the effects of DCCD inhibition at the single
channel level. This assay can be utilized to distinguish between single-hit kinetics and
other models of inhibition. There are three parameters of our assay that will change
upon inhibition of FO by DCCD. No matter which model is correct, the total initial
slope, which is the slope of the line fitted to the valinomycin signal, should be
reduced. If the single-hit model is accurate, the slope will be reduced because the
there are fewer functional channel, but each active channel is fully functional. If the
multiple-hit model is accurate the slope will be reduced because most channels are
active, but there is a mix of fully and partially active channels.
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Second, the number of functionally incorporated FO per µg total protein
assayed will be reduced in the single-hit model, but unaffected in the multiple-hit
model. The number of function FOs is calculated from the proportion of vesicles that
exhibit proton flux within 5 minutes after addition of valinomycin to the number
which equilibrate the membrane charge after addition of CCCP. This ratio is then
used to generate a Poisson distribution to determine the number of vesicles that have
0, 1, 2, or more functional FOs. Since the number of vesicles can be determined from
the total lipid concentration, the vesicle diameter, and the area per lipid headgroup, the
number of total function FO sectors can be calculated. Under the single hit hypothesis,
treatment of FO with even low concentrations of DCCD will completely inhibit some
FOs. Vesicles in which FO is completely blocked will simply appear to have no
functional FO, and in our assay will not exhibit proton flux upon addition of
valinomycin. This will increase P0, the number of vesicles with 0 functional FOs.
However, if a single hit by DCCD only reduces proton flux by 50%, then all vesicles
with FO hit once should still equilibrate protons over the five minutes before addition
of CCCP. However, any FO hit twice or more times will likely show no proton flux
and will only equilibrate protons upon addition of CCCP. Thus, the total number of
functionally incorporated FO in this second case will show a reduced number of
functionally incorporated sectors, depending on the number of FOs that are hit multiple
times. If numerous different concentrations of DCCD are used this assay could be
utilized to generate a Hill coefficient for FO block. This would be an important
contribution to the field and should be an avenue of further research.
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Third, the single channel measurement should be unaffected in the single-hit
model, but reduced in the multiple-hit model. Using a similar argument as the above
paragraph, it can be expected that if FO is blocked under a single-hit model, the single
channel proton flux measured by this assay will remain the same as with untreated
samples. Any unblocked FO sectors will pass protons with addition of valinomycin,
yielding a high single channel conductance. However, if a single hit of DCCD is only
partially effective, a reduction in the single channel flux will be seen.
During the treatment with DCCD and subsequent purification of FO from E.
coli membranes preparation, Dr. Brusilow split the sample into two parts after the
membranes had been isolated. One part was treated with DCCD so that the ATP
synthase activity was reduced to about 50% of the untreated. The other part was
untreated. The membranes were then stripped, FO purified, and shipped to our lab in
Provo. A second preparation was performed by Dr. Brusilow such that the ATP
synthase activity of the treated membrane was reduced to about 80% of the untreated.
The proton flux activity of all four protein preparations was assayed at several protein
concentrations. Table 3-1 summarizes the values of FO activity in moles H+ per
second per µg protein, number of functionally incorporated FOs per µg, and the single
channel flux in H+ per FO per second. The standard deviations for each measurement
are also reported in Table 3-1.
The single channel flux of FO extracted from this new deletion strain is smaller
than the 3100 ± 500 H+/FO/sec reported previously by Franklin (12) using the proton
flux assay. Although there is the possibility that this represents a true difference in the
deletion strain, the difference may be due to the ethanol artifact that required
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postponement of data collection for a few seconds after addition of valinomycin. To
examine this hypothesis 16 experiments were performed on extracts from the wildtype strain to compare independently with the deletion strain data. The single channel
flux was 1910 ± 1110 H+/FO/sec. The difference between the wild-type and the
deletion fluxes was not significant in a one-sided t-test (p < 0.22). Therefore, FO
purified from wild-type and deletion strains of E. coli had statistically similar levels of
proton flux. It is likely that the true rate of proton flux lies between 3100 and 1900
H+/FO/sec.
Table 3-2 summarizes the percent change of activity of the DCCD treated
samples as a percent of the paired untreated protein extract and as a percent of the
combined untreated extracts. The proton flux of FO from the 50% ATP synthase
sample shows a reduction to 27% from the untreated sample; while the FO activity of
the 20% ATP synthase sample shows a 13% reduction. The data suggest that the more
DCCD utilized, the greater the reduction in FO activity. Further details from both
tables are presented graphically in Figure 3-6 through Figure 3-8, which summarize
the data relevant to the single-hit hypothesis from the two sets of paired DCCD-treated
deletion strain samples.
Figure 3-6 graphically presents the reduction in initial total flux in moles H+
per second per µg protein. In the preparation in which 50% of the ATP synthase
activity is inhibited (+), the treated FO (N = 9) shows less total proton flux than
untreated FO (N = 2), showing a reduction to 33% of the untreated. This suggests that
DCCD inhibited passive proton flux through FO. Examining the next preparation
treated with more DCCD, the untreated FO (N = 4) showed a similar activity to the
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previous untreated preparation and the treated (++) is reduced to 12% of the untreated
(N=3). The last bar in the graph combines the two untreated preparations (N = 6).
This data suggests that DCCD inhibition is dose dependant.
Figure 3-7 shows the number of functionally incorporated FO sectors per µg
protein used. “Functional FO” is defined in this assay as any FO that can transport
protons at a rate of at least 20% normal (which is the limit of detection for this assay).
This assay did not give consistent results with the lower dose of DCCD having no
apparent effect but the higher dose caused a reduction when compared to either the
paired untreated sample or the combined untreated samples. This reduction is
significant to a p < 0.038 in a one-sided t-test. Figure 3-8 presents the single channel
flux, in protons per second per FO, of the four deletion strain samples treated (or paired
controls) with DCCD (see tables). The two untreated protein purifications show very
similar single channel fluxes. When these two results are combined, untreated FO
shows a flux of 1610 H+/FO/sec with a standard deviation of 590 H+/FO/sec. The 50%
ATP synthase inhibited sample (+) has a single channel flux of 455 ± 401 H+/FO/sec.
The 80% ATP synthase inhibited sample (++) has a single channel flux of 660 ± 141
H+/FO/sec. These represent an activity that is 28% and 41% as great as the combined
untreated samples. Both of the DCCD treated samples show a significantly reduced
flux compared to the untreated samples (p<0.02) in a one-sided t-test. This suggests
that the single-hit hypothesis for passive proton flux is not correct for this system.

91

Discussion
Elimination of the yraM open reading frame
The proton flux assay, as used in our lab, is capable of detecting changes in pH
on the order of the mpH scale. Our assay utilizes an efflux of potassium, facilitated by
the ionophore valinomycin, to create the membrane potential needed to induce proton
influx through individual FO sectors of the FOF1 ATPase of E. coli that are functionally
reconstituted into liposomes. The potassium efflux and proton influx continue until
the counter-balanced potassium and hydrogen gradients reach a Donnan equilibrium.
This dynamic system is modeled and analyzed in Chapter 2. As published by previous
researchers from our (12) the Poisson distribution can be used to deduce the number of
function FO channels per vesicle. Using dynamic light scattering and the lipid
concentration we can quantify how many vesicles are present per experiment. Single
channel conductance of FO can then be determined based on the total hydrogen flux
upon addition of valinomycin.
With recent advances in genetic sequencing, the genomes of many species
have been entirely sequenced including the bacterium Escherichia coli. These DNA
sequences reveal many open reading frames, which are suspected to encode proteins,
but for which no protein has been reported. The E. coli yraM gene (GenBank
accession number AAC76181), is one such sequence. While studying proton flux
through FO Cao et al. (13) discovered a channel that co-purifies with FO and that leaks
potassium, which was named cation-leak channel (CL). Our collaborator William
Brusilow and co-workers (Wayne State University School of Medicine, Detroit, MI)
attempted to isolated this channel and by sequence analysis deduced it was the yraM
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gene product. They then created a knock-out strain, from which FO has been purified
and its proton flux determined and compared to the wild-type strain.
Cao et al. (13) showed that during proton flux assays, the total signal
(magnitude of pH change following addition of both valinomycin and CCCP) was
reduced when “too much” protein was added. This loss in signal was attributed to CL
eliminating the potassium gradient in some proteoliposomes, thereby rendering them
unresponsive to the addition of valinomycin. It was also shown that heat treatment of
the proteoliposomes removes both proton flux activity and this leak activity,
suggesting that the lead is indeed due to a protein. In his dissertation Dr. Franklin
(27), who also used the proton flux assay to study FO, showed that the reduction in
total signal was dependent on the final concentration of total protein.
If CL were the yraM product, it was expected that FO purified from the strain
with the yraM gene deleted should show a greater total signal than FO purified from
the wild-type strain. Initial results (Figure 3-4) seemed to confirm this hypothesis.
Vesicles made with the wild-type extract have a smaller total signal than vesicles
made with the deletion extract. This difference was attributed to the presence of CL.
FO purified from the deletion strain showed a larger total signal than wild-type, but
less than control. This suggests that CL activity had multiple components, one of
which was eliminated in the deletion strain. The fact that CL does not appear to be
totally lost with the removal of the yraM gene does not preclude it from being the
yraM gene produce. There may be other contaminants that co-purify with FO and that
leak cations besides CL. This latter hypothesis seems more likely the case since the
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deletion showed a marked improvement in total signal (3.6x larger) compared to wildtype. This argues that CL is the major contaminant cation channel.
However, upon repeating the assay for a total of 35 wild-type assays and 64
deletion assays over many protein concentrations the data argue that CL activity was
not deleted. Figure 3-5 shows the results after normalizing the protein concentration
for each assay from the same protein preparation. The exponential fit of the total
signal of the deletion samples fall more quickly than that of the wild-type samples.
This difference is significant to a p value < 0.021 (as determined by ANOVA). These
data suggest that deletion of the yraM open reading frame actually made the cationleak worse. This leads to the question of what the yraM gene product really is.
A possible clue to the role of the yraM gene product is the observation that the
deletion strain grew quicker than the wild-type strain. Let’s assume that yraM does
encode for one of the constituents of CL and another constituents is a metabolic waste
product or a protein essential for growth. If the wild-type and the deletion strains are
in different stages of growth it is possible that the decrease in total signal in deletion
may be due to a build up of the other constituent. This hypothesis can be tested by
separating the data according to the extent of growth in each preparation, as measured
by OD at the time of harvest. The ratio of the total signal was then examined
according to differences in growth. As presented in Figure 3-5, the average of all
samples shows a negative correlation (downward decay) of total signal as a function of
protein. However, in the deletion strain, the higher OD prep (~OD 2) was flat with
protein concentration, i.e. addition of more protein did not decrease the total signal
based on 9 experiments. The lower OD (~OD 1.3) FO preparations from deletion
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strain (N = 8) and all the wild type preparations had a negative correlation with protein
concentration. Specifically, in the wild-type strain the high OD (OD 4, N = 3) showed
a negative correlation with protein concentration, as did the low OD (OD 1.3 - 1.7, N
= 18), but the high OD cells had less total signal than the low OD cells. From these
data we can conclude that growth conditions may have an effect on total signal. If
they do, one component of CL may likely be involved in growth or a metabolic waste.
Further studies on the dependence of total signal on the growth conditions may clarify
new roles of CL and the yraM open reading frame.
The most convincing evidence that the yraM open reading frame expresses the
CL channel would be to put the open reading frame into an E. coli expression vector,
express the gene product, and study the channel-like properties using
electrophysiology (e.g., a bilayer set-up). These properties could then be compared
with the properties of CL, which have been reported by Cao et al. (13). Confirmation
of cation-like channel properties with the purified yraM gene product would be
conclusive evidence it is the CL gene. Such studies are suggested to future
researchers.
Model for Inhibition of FO by DCCD
Fillingame et al. (17,18,19,20,21) have suggested that one molecule of DCCD
is sufficient to inhibit passive proton flux through an individual FO sector. Our assay
has the sensitivity to detect proton flux through FO in response to a voltage gradient at
the single channel level. It also has the ability to distinguish vesicles with zero
functional FO sectors reconstituted from vesicles with at least one partially active
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channel. As described in Results, these aspects have been used to model how our
assay would be affected under the assumption of single-hit kinetics.
As expected for both the single-hit and multiple-hit models, the total initial
slope decreased with treatment of DCCD (Figure 3-6). This response appears to be
dose-dependent. Figure 3-7 shows that only the higher treatment with DCCD had any
affect on the number of function FO channels per µg protein. This supports the two-hit
model for passive proton flux based on the following. If ATP synthase activity is
inhibited by one DCCD per FO, then at least 80% FO were hit at least once with
DCCD. Using the Poisson distribution 50% FO were hit at least twice and therefore
totally inhibited. Therefore we expected a 50% reduction in the number of functional
FO. The difference between the uninhibited and the inhibited are different from a 50%
reduction. These data suggest that the two-hit model is correct (but not a four-hit
model). In the sample treated with less DCCD, using a similar argument we expected
only a 16% reduction in the number of functional FO. Our assay is not sensitive
enough to resolve such a small reduction.
The most conclusive evidence for a multiple-hit model is seen in Figure 3-8,
which shows a reduction in the calculated single channel flux with treatment of
DCCD. If the single-hit model accurately described passive proton flux, then this
number would be unaffected by treatment with DCCD because any vesicles containing
FO that was hit by even one DCCD would act like protein-free vesicles while any unhit vesicles would exhibit normal proton flux. In our experiments only a few percent
of vesicles had multiple copies of FO, so they would not noticeably reduce the single
channel flux in a single-hit scenario. However, the data show that there a significant
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reduction (both p < 0.02 in a single-sided t-test) in single channel flux, suggesting that
addition of DCCD in single-hit stoichiometries causes FO to passively transport
protons at a lower but non-zero rate.
There are three key findings of these studies. First a cation-leak channel CL,
which in our assay reduces the total signal, was not sufficiently linked to the gene
product of the open yraM reading frame. Measurements of the total signal of FO
isolated from wild-type and deletion strains did not show a significant recovery of
signal and therefore we cannot confirm identification of the yraM gene product as CL,
but the gene may alter cell growth. Second, FO isolated from this new deletion strain
exhibits similar activity as FO isolated from the wild-type strain. Third, using several
parameters of the proton flux assay it was determined that the inhibition of FO by
DCCD is more complex than the single-hit hypothesis. It appears that a single-hit
reduces, but does not eliminate proton flux through FO. The data are consistent with a
two-hit model.
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Figures

1, 2, 3, 4, 5, 6, 7
Wt, Del, Del, Wt, Del, Del, Ldr

70 kDA
50 kDA

20 kDA

Figure 3-1 – Comparison of protein isolated during FO extraction from wild type and
deletion E. coli strains. The lanes contain FO purified from either wild-type or
deletion E. coli, as labeled at the top. Lane 7 is a molecular weight standard. Lane 4
shows a wild-type preparation with a dark double at about 40 kDa, which is not
present in the other wild-type preparation (lane 1).
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100 nmoles H+

2 minutes

Figure 3-2 – Representative pH tracing of a proton flux assay. Vesicles were added at
time zero (not shown). Ethanol, the solvent for valinomycin and CCCP, was added
after 3 minutes (diamond). Valinomycin, a potassium ionophore, induces a membrane
potential at 5 minutes (arrow). CCCP, a protonophore, was added at 10 minutes,
serving as a positive control for vesicles without functional FO (arrowhead). Two
additions of 100 nmoles of HCl serve as a standard calibration for buffer strength.
The line through the valinomycin addition shows the fit of the initial slope to the pH
curve after addition of valinomycin, as described in Methods. This slope of the line
after valinomycin addition is corrected by taking into account the slope of the pH drift
(not shown).
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100 nmoles H+

2 minutes

Figure 3-3 – pH trace emphasizing the ethanol artifact from a different experiment
than Figure 3-2. Addition of ethanol is shown by the diamond and addition of
valinomycin (in ethanol) is shown by the arrow.

100

100 nmoles H+

ProteinFree

2 minutes

Deletion

Wild-type

Figure 3-4 – Total signal from FO purified from wild-type and deletion strains versus
a protein-free control. The same concentration of total protein was assayed on the
same day. Vesicle diameters were similar in all three preparations. The greater total
signal in vesicles containing FO purified from the deletion strain suggest that deletion
of the yraM open reading frame is responsible for the larger signal. The fact that the
total signal of the deletion does not match control, suggests that a second leak may
also contribute to K+ leak in reconstituted vesicles. Addition of valinomycin is shown
by the arrow and the addition of CCCP is shown by the arrowhead.
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Figure 3-5 – Plot of the ratio of total signal of FO isolated from wild-type and deletion
E. coli strains versus the ratio of concentration of reconstituted protein. The plot shows
total signal as a function of total protein isolate (in µg protein in the reaction vial).
The trend lines are exponential fits. The difference between these the exponential fits
(as determined by ANOVA) is significant to p < 0.021.
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Mol
H+/Sec/µg

Stdev

Functional
Fo/µg

Stdev

Single
Channel Flux

Stdev

N

Untreated

8.97E-11

3.52E-11

3.3E+10

1.76E+10

1708

269

2

50% ATP
Synthase

2.93E-11

2.66E-11

3.8E+10

2.06E+10

455

401

9

Untreated

1.17E-10

2.72E-11

5.5E+10

3.08E+10

1555

734

4

20% ATP
Synthase

1.37E-11

2.04E-12

1.3E+10

4.13E+09

660

141

3

Both Untreated

1.08E-10

2.99E-11

4.7E+10

2.75E+10

1606

586

6

Table 3-1 – Results of the proton flux assay in four preparations. One in which the
ATP synthase activity is reduced by ~50%, one in which it is reduced by 80%, and the
parallel, but untreated purifications. Also shown are the data when the results from
the two untreated samples are pooled.
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% Fo
Activity
Untreated

Untreated
Combined

100%

50% ATP Synthase

33%

Untreated

100%

20% ATP Synthase

12%

% Incorporation

Untreated
Combined

100%
27%

114%
24%

Untreated
Combined

100%
79%

100%
13%

% Single Channel
27%

28%

100%
27%

42%

41%

Table 3-2 – Change in the response of the proton flux assay to DCCD treatment. The
percent change is also shown when the results from the two untreated preparations are
combined.
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Initial Flux Normalized for Total Protein

Initial Flux (mol H+/sec/ug)

1.40E-10
1.20E-10
1.00E-10
8.00E-11
6.00E-11
4.00E-11
2.00E-11
0.00E+00

Treatment

+

++

Figure 3-6 – The initial total proton uptake through FO is altered by the addition of
DCCD (+ = low dose, ++ = high dose). Black bars to the left of each treated sample
are the untreated paired controls. The right bar is the average of both untreated
samples. FO activity is reported as moles H+/second/µg protein. The error bars show
one standard error in this and all subsequent charts.
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Number of Active Fos per ug Total Protein
7.00E+10

Active Fos (per ug)

6.00E+10
5.00E+10
4.00E+10
3.00E+10
2.00E+10
1.00E+10
0.00E+00
Treatment

+

++

WT

Figure 3-7 – The number of functionally reconstituted FO channels per µg protein.
Most of the preparations provide similar numbers of active channels after purification
and reconstitution, although treatment with the highest amount of DCCD, which
caused 80% ATP synthase inhibition (++), reduced the number of functional FOs.
Since these samples are all from deletion strain; the number of FOs per µg protein
incorporated from all wild-type (WT) preparations (N = 20) is also shown for
comparison.
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Single Channel Flux

2000
1750

H+/Fo/sec

1500
1250
1000
750
500
250
0

Treatment

+

++

Figure 3-8 – Calculation of the single channel flux. FO treated with DCCD shows a
significant reduction in proton conductance. These reductions are significant to a p<
0.02 in a single sided t-test. See text for further discussion; columns are same as in
Figure 3-6.
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Chapter 4 – Concluding Remarks
Protons and proton gradients play a number of crucial roles in homeostasis of
organisms. In the life cycle of the Influenza A virus the proton channel M2 is the key
player responsible for sensing the right conditions to initiate viral uncoating via a pH
sensitive gate, the first such mechanism suggested. Once activated, M2 passes protons
into the virus capsid which triggers viral replication. In the synthesis of ATP almost
all living species use some form of the FOF1 ATPase. This enzyme turns a preestablished proton gradient (PMF) into rotary motion, driving the reaction:
ADP + Pi

ATP.

This thesis utilized an assay where a K+ gradient-induced membrane potential
drove proton influx into vesicles, thereby detecting the activity of functionally
reconstituted M2 or FO channels. The results of the proton flux activity were
examined to discriminate useful information about channel function and inhibition.
Three key features of M2 function were clarified during the course of our
studies. The acid-activation of M2 has often been claimed based on a relatively small
(2 – 10 fold) increase in channel conductance in the presence of a large change in H+
concentration (30 – 100 fold). However, a large change in conductance is expected
due solely to the increased presence of H+ in the bath at lower pH. The fact that there
is little or no increase in conductance at more acidic pHs suggests that some step in the
translocation process, perhaps a titratable site within the conduction pathway, is
already saturated by pH 7. This site was postulated to be histidine-37. Also, Chapter
2 shows that the block of M2 by amantadine is reduced at pH 5.4. Finally, previous
studies using assays similar to ours have concluded that M2 and other proteins are
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highly selective to protons compared to other cations. Using a mathematical model
created by Dr. Busath in conjunction with experiments using gramicidin, a mildly
selective ion channel, it was shown that selectivity for hydrogen only need be a factor
of about 10 times that of potassium to observe a valinomycin-induced proton signal.
In contrast to gramicidin, it was determined in this study that M2 is 107 times selective
for protons over potassium.
Three key findings of using our proton flux assay on FO extracts from E. coli
were discovered together with our collaborator, Dr. Brusilow. First a cation-leak
channel CL, which in our assay reduces the total signal, was potentially linked to the
gene product of the open yraM reading frame. A strain was created in which the yraM
gene was deleted from the E. coli genome. Measurements of the total signal from FO
isolated from wild type and deletion strains did not show a significant recovery of
signal and therefore we can not confirm identification of the yraM gene product as CL.
However, differences in growth rates of the wild-type and the deletion strain suggest
that other contaminating channels may also reduce the total signal in our proton flux
assay. It was established that FO isolated from this new deletion strain exhibits similar
activity as FO isolated from the wild-type strain. Finally, it is known that DCCD
blocks proton flux through FO by binding to the c-subunit ring responsible for proton
translocation. However, the stoichiometry of this inhibition has been a matter of
debate in the literature and is often reported to be one DCCD per FO. Using several
parameters of the proton flux assay it was determined here that the inhibition of FO by
DCCD is more complex than the single-hit hypothesis. It appears that a single hit (one
DCCD binding to one c subunit of the c-ring) reduces, but does not eliminate passive
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proton flux through FO. The data are consistent with a two-hit model but not a four or
more hit model.
In both studies one essential aspect of determining the flux per channel was the
estimation of the number of active channels. In the M2 studies, the nominal protein
concentration (40.5 µg at pH 5.4 and 15 µg at pH 7.0) was used with the assumption
that the preparation contained no contaminating channels and that all the M2 was fully
functional. In the FO studies the Poisson distribution was utilized, assuming that any
functional FO had no gating and would fully equilibrate the vesicular membrane
potential during 5 minutes after addition of valinomycin. The average number of
functional FO channels was 6x1011 in the DCCD studies. If we use the nominal total
protein concentration of 21.4 µg, the average protein concentration in the DCCD
experiments, to calculate the expected number of functional FO channels we expect 8.1
or 9.5x1013 functional FO channels (containing 9 or 12 c subunits, respectively).
Using the nominal protein density greatly overestimates the number of functional FOs
(by ~150X). This was expected since the protein preparation is far from pure (See
Figure 3-1). However, the M2 preparations are much purer due to the use of a His-tag
during purification. The M2 gel (See Figure 2-1) shows M2 to be the major protein
purified. Therefore the nominal protein calculation used in Chapter 2 should be
correct within a factor of 2 – 5. This would mean that M2 may conduct protons at a
rate of as high as 1 – 2.5 H+/tetramer/sec at pH 7.
Although the mechanisms of proton transport through M2 and FO are quite
different, both channels conduct protons: M2 at 0.5 H+/tetramer/second and FO at 1600
H+/FO/second. Therefore the time-averaged proton flux of FO is ~3200 times that of
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M2. However, if M2 is only in the open state 1/1000th of the time, both channels
conduct protons equally well in the open state. The idea that FO can continuously
conduct at such a rate without stalling out is intriguing. Protons must be delivered to
the mouth of the pore at least that quickly. Lipid headgroup buffering may play a role
in recruiting protons to the pore, but even at pH 7 we are above the pKa of PE and PG,
the major components of the E. coli lipid extract used in FO reconstitution (1). More
likely simple diffusion of H+ through water or H+ transported by the buffer to the pore
is sufficient to supply the necessary protons. In any event, the FO proton current
measured in this study (on the order of 1 pS) is far less than the 300 pS to 1000 pS
reported for gramicidin at pH 7 by Cukierman (2).
It is possible our observed proton flux was limited by valinomycin transport of
K+, but this rate has been shown to be 104 per second (3) in a 1 M potassium solution
and enough valinomycin was added so that each vesicle contained many molecules.
Thus, the rate of proton transport through FO was orders of magnitude smaller than the
valinomycin transport of potassium, as confirmed in our experimental observation that
our proton flux did not increase when the amount of valinomycin was doubled or
when valinomycin was added twice.
Numerous avenues are now open for further research of proton conduction in
both M2 and FO. In the M2 project there are many parameters that are yet to be
studied, such as dose response curves using different concentrations of M2 and of
amantadine, internalization of amantadine, reconstituting M2 by various methods such
as dialysis, more thoroughly measuring proton flux with changes in pH for studying
acid activation and His37 titration, and evaluation of M2 protein orientation in smaller
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vesicles. It is highly recommended to attempt the pH 9 studies using a different buffer
species, particularly a non-organic species that is not lipid permeable.
In the FO project the confirmation of the cation-like channel properties of an
expression construct containing the yraM gene would be the most conclusive evidence
to show that it is the CL gene (if it is). Future research using the proton flux assay
would benefit from elimination of the ethanol artifact, which has reduced the
sensitivity of the current assay by causing a small pH jump upon addition of
valinomycin. This may be accomplished by titration of the ethanol with concentrated
HCl. Conversely, the ethanol artifact may be eliminated by dissolving valinomycin in
DMSO a non-titratable solvent. If the artifact can not be eliminated, the use of
nonlinear curve fitting, may allow for a more careful determination of the FO proton
flux rate. This could be accomplished by modifying the Excel spreadsheet I created to
fit the initial data to an exponential curve rather than a line or it could be accomplished
with the help of Dr. Barry Willardson in the Chemistry Department, who uses a
different program to fit data curves. Finally, the determination of the Hill coefficient
of the stoichiometry of DCCD inhibition of passive proton flux through FO has not
been determined. Our assay has the unique possibility of determining this coefficient
on a single channel level. This would serve as the final essential piece of evidence
supporting or refuting the single-hit hypothesis.
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